NCT03486119
A Study for Identification of Predictive Immune Biomarker in Peripheral Blood for Nivolumab Therapy in NSCLC Patients No drug interventions Not Available Not Available completed NCT05585034
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors treatment 1 recruiting NCT06618391
Local Injection and Systemic Therapy in the Treatment of NSCLC. treatment 2 not_yet_recruiting NCT06620822
Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial treatment 2 not_yet_recruiting NCT06621147
Application of Machine Learning Algorithms to Identify Optimal Candidates for Primary Tumor Resection in Patients with Metastatic Non-small Cell Neuroendocrine Tumors No drug interventions Not Available Not Available completed NCT06621563
Phase Ib Trial of HS-20117 in Combination with Other Drugs in Advanced Solid Tumors treatment 1 not_yet_recruiting NCT00068003
Harvesting Cells for Experimental Cancer Treatments No drug interventions Not Available Not Available enrolling_by_invitation NCT01899989
Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer treatment 1 completed NCT02146170
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors No drug interventions Not Available Not Available recruiting NCT02682667
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols No drug interventions Not Available Not Available recruiting NCT02775435
A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407) treatment 3 completed NCT06622174
Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer No drug interventions treatment 1 not_yet_recruiting NCT06623136
A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer treatment 2 not_yet_recruiting NCT02838836
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers No drug interventions Not Available Not Available recruiting NCT03178552
A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) treatment 2 / 3 recruiting NCT03412877
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer treatment 2 recruiting NCT03515837
Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789) treatment 3 completed NCT03551951
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow No drug interventions Not Available Not Available recruiting NCT03808337
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease No drug interventions treatment 2 recruiting NCT03875092
A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)-China Extension Study treatment 3 completed NCT04140500
Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors treatment 1 / 2 active_not_recruiting NCT04609566
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors treatment 2 recruiting NCT04611867
Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) No drug interventions supportive_care Not Available recruiting NCT04886804
A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) treatment 1 recruiting NCT06624059
A Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC) treatment 2 not_yet_recruiting NCT04913337
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies treatment 1 / 2 active_not_recruiting NCT04926831
Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC treatment 2 completed NCT04928846
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) treatment 3 recruiting NCT05029882
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab treatment 1 recruiting NCT05062980
Quaratusugene Ozeplasmid (Reqorsa) in Combination with Pembrolizumab in Previously Treated Non-Small Lung Cancer treatment 1 / 2 active_not_recruiting NCT05256381
A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors treatment 2 active_not_recruiting NCT05275868
Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 recruiting NCT05363319
An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe Not Available Not Available recruiting NCT05401110
Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer treatment 1 recruiting NCT05569291
Investigating the Feasibility of a Physical Activity (tele)coaching Intervention in Patients with Non-small Cell Lung Cancer: an Explorative Study No drug interventions treatment Not Available completed NCT05571839
A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors No drug interventions treatment 1 recruiting NCT05635708
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer treatment 2 recruiting NCT05642195
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer treatment 1 / 2 suspended NCT05669430
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination with Pembrolizumab in Participants with Solid Tumor Malignancies treatment 1 / 2 recruiting NCT05688280
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS No drug interventions treatment 1 / 2 recruiting NCT05765734
A Study of TAS3351 in NSCLC Patients With EGFRmt No drug interventions treatment 1 / 2 recruiting NCT05782361
POTENT - Tepotinib in Combination with Pembrolizumab in NSCLC health_services_research 1 recruiting NCT05789082
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation treatment 1 / 2 recruiting NCT05858164
A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors No drug interventions basic_science 1 recruiting NCT06068842
A Study to Assess Prevalence of a Specific Protein Overexpression in Adult Participants with Non-Small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT06077760
A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) treatment 3 recruiting NCT06120283
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors treatment 1 recruiting NCT06236438
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) treatment 2 / 3 recruiting NCT06249854
Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer treatment 2 recruiting NCT06253520
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer treatment 1 recruiting NCT06272864
BostonGene and Exigent Genomic INsight Study No drug interventions Not Available Not Available recruiting NCT06284317
A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients with Early-stage, Operable, Non-small Cell Lung Cancer. treatment 3 not_yet_recruiting NCT06303505
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients with PROC or R/r Adenocarcinoma NSCLC No drug interventions treatment 1 / 2 recruiting NCT06333951
AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) treatment 1 recruiting NCT06463665
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer treatment 2 recruiting NCT06497556
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer treatment 3 recruiting NCT06626243
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers No drug interventions Not Available Not Available recruiting NCT06540196
The Development, Safety, and Feasibility of an Artificial Intelligence-Powered Platform (NodeAI) for Real-Time Prediction of Mediastinal Lymph Node Malignancy During Endobronchial Ultrasound Staging for Lung Cancer No drug interventions diagnostic Not Available not_yet_recruiting NCT06546553
A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. treatment 1 recruiting NCT06562192
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers treatment 1 recruiting NCT04566393
Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered Malignancies Not Available Not Available available NCT04606771
A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC treatment 2 active_not_recruiting NCT04644068
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies treatment 1 / 2 recruiting NCT04721223
JAB-3068 Activity in Adult Patients With Advanced Solid Tumors treatment 1 / 2 completed NCT04746924
A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer treatment 3 active_not_recruiting NCT04777175
A Retrospective Study: Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT04895709
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors treatment 1 / 2 recruiting NCT04965818
Phase 1b/2 Study of Futibatinib in Combination With Binimetinib in Patients With Advanced KRAS Mutant Cancer treatment 1 terminated NCT04977453
GI-101 As a Single Agent or in Combination with Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors treatment 1 / 2 recruiting NCT04985604
Tovorafenib (DAY101) Monotherapy or in Combination With Other Therapies for Patients With Melanoma and Other Solid Tumors treatment 1 / 2 active_not_recruiting NCT04999761
AB122 Platform Study treatment 1 recruiting NCT05014464
ALK Tyrosine Kinase Inhibitors in ALK-rearranged Advanced Squamous Cell Carcinoma treatment 2 recruiting NCT05047250
A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer treatment 3 recruiting NCT05061550
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer treatment 2 recruiting NCT05120349
A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour Resection treatment 3 active_not_recruiting NCT05170204
A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC) treatment 3 recruiting NCT05195632
Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients with Metastatic Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT05211895
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC treatment 3 recruiting NCT05227326
AOH1996 for the Treatment of Refractory Solid Tumors No drug interventions treatment 1 recruiting NCT05239143
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT05274451
A Study to Investigate LYL797 in Adults with Solid Tumors No drug interventions treatment 1 recruiting NCT05295212
Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIB treatment 2 recruiting NCT06606847
A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA) treatment 2 not_yet_recruiting NCT06607185
A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors treatment 1 not_yet_recruiting NCT05358249
Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation treatment 1 / 2 active_not_recruiting NCT05379803
High-dose Furmonertinib for First-line Treatment of EGFR Mutated NSCLC With Central Nervous System (CNS) Metastases treatment 2 recruiting NCT05467748
EZH2 Inhibitor, Tazemetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer treatment 1 / 2 not_yet_recruiting NCT05491811
Ensartinib in Combination With Bevacizumab in ALK-positive NSCLC Patients With TP53 Mutation treatment 2 active_not_recruiting NCT05522660
Immunotherapy or Targeted Therapy with or Without Stereotactic Radiosurgery for Patients with Brain Metastases from Melanoma or Non-small Cell Lung Cancer No drug interventions treatment 3 recruiting NCT05551117
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors treatment 2 active_not_recruiting NCT05573035
A Study to Investigate LYL845 in Adults With Solid Tumors No drug interventions treatment 1 recruiting NCT05578092
A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway treatment 1 / 2 recruiting NCT05616624
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers treatment 1 / 2 recruiting NCT05620134
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer treatment 1 / 2 recruiting NCT05653752
A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer No drug interventions treatment 1 recruiting NCT05703269
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy No drug interventions supportive_care Not Available recruiting NCT05714553
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours treatment 1 / 2 recruiting NCT05766800
Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer treatment 2 recruiting NCT05783622
Study of JANX008 in Subjects with Advanced or Metastatic Solid Tumor Malignancies No drug interventions treatment 1 recruiting NCT05816252
A Study of SKB264 for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) treatment 2 recruiting NCT05863052
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population No drug interventions Not Available Not Available active_not_recruiting NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05867121
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-Care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT05877599
A Study of NT-175 in Adult Subjects with Unresectable, Advanced, And/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation No drug interventions treatment 1 recruiting NCT05882734
Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322) treatment 1 / 2 active_not_recruiting NCT05891197
A Biomarker Screening Protocol for Participants With Solid Tumors No drug interventions Not Available Not Available recruiting NCT05902260
The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC No drug interventions treatment Not Available completed NCT05925530
Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE) treatment 2 recruiting NCT06003075
Induction Chemo-Nivo in Unresectable Stage III NSCLC treatment 2 terminated NCT06010329
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC No drug interventions treatment 2 recruiting NCT06029127
A Study of BGB-A445 in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT06057766
Physical Activity Coaching After Surgery for Patients with Resectable Non-small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT06068049
OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain No drug interventions Not Available Not Available recruiting NCT06099782
A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11) treatment 2 recruiting NCT06105021
Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor No drug interventions treatment 1 / 2 recruiting NCT06141226
Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Chemotherapy in the Treatment of Immunoresistant Advanced Non-small Cell Lung Cancer treatment 2 recruiting NCT06147037
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients with Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT06192004
Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD No drug interventions Not Available Not Available recruiting NCT06208124
A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06218914
A Study of NT-112 in HLA-C*08:02-Positive Adult Subjects with Unresectable, Advanced, And/ or Metastatic Solid Tumors Positive for the KRAS G12D Mutation No drug interventions treatment 1 recruiting NCT06228326
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs No drug interventions treatment 1 recruiting NCT06238479
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT06305715
Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X) No drug interventions treatment 2 recruiting NCT06312137
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) treatment 3 recruiting NCT06345729
A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant, Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004) treatment 3 recruiting NCT06348927
Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR-Sensitive Mutations Combined With Co-Mutations Advanced NSCLC treatment 2 recruiting NCT06350097
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 3 recruiting NCT06355609
Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR Mutant Advanced NSCLC-RW treatment 2 recruiting NCT06362369
A Study of Oral 7HP349 (Alintegimod) in Combination with Ipilimumab Followed by Nivolumab Monotherapy treatment 1 / 2 recruiting NCT06382129
A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer treatment 3 recruiting NCT06385262
TOP 2301: Neoadjuvant Chemo for NSCLC treatment 2 not_yet_recruiting NCT06422143
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023] treatment 3 recruiting NCT06444815
A Study of VET3-TGI in Patients With Solid Tumors treatment 1 recruiting NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors No drug interventions treatment 1 recruiting NCT06477055
The Recurrence Gene Profiles of Adjuvant Osimertinib Therapy in Resected Non-Small-Cell Lung Cancer treatment 2 not_yet_recruiting NCT06612840
A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06537297
Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases treatment 2 not_yet_recruiting NCT06538038
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients Not Available Not Available recruiting NCT06561386
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 1-49% treatment 3 recruiting NCT06561685
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT06575933
A Study of MK-1084 With Midazolam and Digoxin in Healthy Participants (MK-1084-009) treatment 1 active_not_recruiting NCT06586515
A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors treatment 1 not_yet_recruiting NCT06586801
The Patient-Reported Outcomes in ALK Positive Advanced NSCLC in China No drug interventions Not Available Not Available not_yet_recruiting NCT06589778
A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 1 / 2 not_yet_recruiting NCT06594874
A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors treatment 1 not_yet_recruiting NCT06596915
Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06598839
Immuno-effect of Tα1 for Stage I NSCLC treatment Not Available recruiting NCT06602661
Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy No drug interventions treatment 1 not_yet_recruiting NCT06604351
Bronchoscopic Cryoablation Combined With Chemo-Immunotherapy in NSCLC With Central Airway Obstruction treatment 2 not_yet_recruiting NCT00845143
Vibration Response Imaging (VRI) in the Preoperative Management in Patients With Non-Small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT02006043
Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-) treatment 2 unknown_status NCT04450043
The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance No drug interventions supportive_care Not Available unknown_status NCT01015443
Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population treatment 3 terminated NCT00160043
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer. treatment 2 completed NCT00212043
Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma treatment 2 completed NCT00153803
Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT00404703
A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer treatment 2 terminated NCT02798003
Food Reward in Cachexia Induced by Acute or Chronic Disease No drug interventions Not Available Not Available terminated NCT05005403
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of ABBV-514 Alone or in Combination With Budigalimab treatment 1 recruiting NCT06093503
Study of Intravenous Telisotuzumab Vedotin in Combination Osimertinib or Standard of Care Chemotherapy to Assess Change in Disease Activity in Adult Participants With Non-Small Cell Lung Cancer That Has a Mutation in the Epidermal Growth Factor Receptor Gene and That Overexpresses the c-Met Protein treatment 3 withdrawn NCT00732303
Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer treatment 2 terminated NCT06127303
Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC treatment 2 not_yet_recruiting NCT06015503
A Phase Ⅱ Study Assessing the Safety and Efficacy of PLB1004 in EGFR ex20ins Mutation Patients With Advanced and Metastatic Non-small Cell Lung Cancer(NSCLC) No drug interventions treatment 2 recruiting NCT01941303
Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent Disease No drug interventions Not Available Not Available completed NCT03637803
Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors treatment 1 / 2 terminated NCT03565003
A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China treatment 1 / 2 unknown_status NCT04933903
BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab treatment 2 recruiting NCT05212103
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9 No drug interventions Not Available Not Available enrolling_by_invitation NCT04272203
A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated Cancers No drug interventions treatment 1 terminated NCT01803503
Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors treatment 2 unknown_status NCT05867303
A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT04322890
Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation treatment 2 recruiting NCT03273790
A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Japan No drug interventions Not Available Not Available completed NCT01187290
Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases No drug interventions treatment 2 unknown_status NCT02914990
Safety, Tolerability and Pharmacokinetic Profile of BPI-15086 in EGFR T790M Mutation-positive NSCLC Patients No drug interventions treatment 1 completed NCT05647590
SBRT/RT in Oligometastatic Stage IV NSCLC No drug interventions treatment Not Available recruiting NCT01510990
First Line Gefitinib by FDG-PET Metabolic Response treatment 2 unknown_status NCT02638090
Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC) treatment 1 / 2 active_not_recruiting NCT02929290
Safety, Efficacy and Pharmacokinetic of BPI-9016M in Patients With c-Met- Dysregulated Advanced NSCLC No drug interventions treatment 1 recruiting NCT02618590
A Retrospective Study About Treatment Strategy After First/Second Line EGFR-TKI Failure No drug interventions Not Available Not Available unknown_status NCT02147990
Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer treatment 2 terminated NCT04840290
A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC treatment 3 unknown_status NCT05465590
A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer No drug interventions treatment 0 withdrawn NCT02658890
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread treatment 1 / 2 completed NCT00078390
Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT02027090
High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease treatment 2 unknown_status NCT06496490
A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality No drug interventions treatment 2 recruiting NCT06343064
Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKI treatment 1 / 2 recruiting NCT03366064
Haploidentical NK Cells After Pemetrexed in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT02040064
Tolerability and Efficacy of Tremelimumab in Combination With Gefitinib in NSCLC Patients treatment 1 completed NCT01527864
Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer treatment 2 unknown_status NCT05698264
A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC No drug interventions treatment Not Available not_yet_recruiting NCT04253964
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy treatment 2 recruiting NCT06060964
Enabling Remote Access to Breathe Easier: A Novel Approach to Improve Symptom Management No drug interventions supportive_care 0 not_yet_recruiting NCT03743064
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT02579564
Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients treatment 3 unknown_status NCT05847764
Disitamab Vedotin Combined Therapy for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations treatment 2 not_yet_recruiting NCT04257864
Bevacizumab Versus Docetaxel/Erlotinib on Tumor Metrics in Patients With Previously Untreated Advanced Non Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT03137264
Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive Patients No drug interventions Not Available Not Available completed NCT03844464
Safety and Efficacy of Lorbrena No drug interventions Not Available Not Available recruiting NCT03870464
LIFE - Lung Cancer, Immunotherapy, Frailty, Effect No drug interventions Not Available Not Available active_not_recruiting NCT01124864
A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy. treatment 2 completed NCT05769764
A Study of Prevalence of HER3 Expression in Non-Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT01003964
Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV treatment 2 completed NCT03130764
Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLC treatment 2 withdrawn NCT03074864
Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLC treatment 2 / 3 unknown_status NCT03256721
Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLC treatment 2 terminated NCT06492421
Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer. treatment 2 recruiting NCT01882621
Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients treatment 3 unknown_status NCT00864721
Sunitinib Non Small Cell Lung Cancer Patients Over 70 treatment 2 completed NCT02259621
Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC treatment 2 active_not_recruiting NCT01045421
Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies treatment 1 / 2 completed NCT00530621
Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer treatment 2 completed NCT03285321
Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC) treatment 2 active_not_recruiting NCT03655821
Dose Individualization of Pemetrexed - IMPROVE-II treatment 4 terminated NCT00741221
Pemetrexed Plus Bevacizumab in Non Small Cell Lung Cancer treatment 2 completed NCT05709821
IMM60 and Pembrolizumab in Melanoma and NSCLC treatment 1 / 2 terminated NCT03735121
A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 3 active_not_recruiting NCT05129202
Outcomes With Immune Checkpoint Inhibitor for Patients With Non-Small-Cell Lung Cancer and Stable Brain Metastases No drug interventions Not Available Not Available completed NCT00818402
Non-small Cell Lung Cancer and Quality of Life No drug interventions Not Available Not Available completed NCT04923802
Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION) No drug interventions Not Available Not Available terminated NCT04438902
Osimertinib Combined With Anlotinib in EGFR T790M Mutated NSCLC Patients With Progression on Osimertinib Treatment treatment 2 terminated NCT05965102
Tirellizumab Combined With Chemotherapy Monotherapy for Non-small Cell Lung Cancer No drug interventions treatment 1 not_yet_recruiting NCT00800202
A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis treatment 2 completed NCT01573702
Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR) treatment 2 completed NCT05354102
A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128 treatment 1 active_not_recruiting NCT02459002
Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot Project No drug interventions Not Available Not Available completed NCT00606502
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment treatment 2 completed NCT01337102
Computer-Generated Quality of Life Assessment Program for Advanced Non-Small Cell Lung Cancer Patients (LUNL2) No drug interventions supportive_care Not Available completed NCT06343402
Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer treatment 1 recruiting NCT04601402
GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy treatment 1 completed NCT04916002
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer treatment 2 active_not_recruiting NCT03840902
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) treatment 2 terminated NCT00674102
An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT04260802
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers treatment 1 / 2 recruiting NCT01225302
A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT00717002
Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study No drug interventions Not Available Not Available completed NCT01211002
Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC) treatment 4 unknown_status NCT00466284
Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer treatment 2 unknown_status NCT03509584
Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients treatment 1 terminated NCT04777084
The Efficacy and Safety of the Bispecific Anti-PD-1/PD-L1 Antibody IBI318 Combined With Lenvatinib in NSCLC. No drug interventions treatment 1 recruiting NCT04491084
FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy treatment 1 / 2 terminated NCT06443684
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC No drug interventions Not Available Not Available recruiting NCT00922584
Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor treatment 2 completed NCT05788484
A Study of CDX-585 in Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT04925284
Study of XB002 in Subjects With Solid Tumors (JEWEL-101) treatment 1 active_not_recruiting NCT05822284
ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction Chemoimmunotherapy No drug interventions Not Available Not Available not_yet_recruiting NCT00367679
Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer treatment 2 completed NCT00907179
Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer treatment 1 terminated NCT00891579
Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations treatment 2 completed NCT01017679
Gefitinib 500mg Versus 250mg in Patients With NSCLC With Stable Disease After a Month Treatment of Gefitinib 250mg treatment 2 completed NCT01544179
A Study of IRESSA Treatment Beyond Progression in Addition to Chemotherapy Versus Chemotherapy Alone treatment 3 completed NCT00188279
Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung Carcinoma No drug interventions diagnostic 2 completed NCT02884479
An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study treatment 1 / 2 unknown_status NCT04967079
Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients treatment 1 completed NCT01130779
The Continuation of Erlotinib treatment 2 unknown_status NCT02841579
Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M treatment 2 completed NCT01059643
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck treatment 2 completed NCT02654587
OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure treatment 3 terminated NCT05956587
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors No drug interventions treatment 2 recruiting NCT00280787
Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim treatment 2 completed NCT03853187
Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer treatment 2 completed NCT00765687
Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates No drug interventions prevention 4 completed NCT00738387
A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer treatment 3 terminated NCT04772287
Adjuvant Toripalimab Plus Chemotherapy for EGFR/ALK Mutation Negative Stage II-IIIB(N2) NSCLC (LungMate-008) treatment 3 not_yet_recruiting NCT03903887
A Study of Anti-PD1 Antibody-activated TILs in Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 unknown_status NCT02349633
Study For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M) treatment 1 / 2 terminated NCT04239833
A Study of SH-1028 Tablets Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 3 unknown_status NCT01041833
Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker treatment 3 unknown_status NCT02803333
Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study No drug interventions Not Available Not Available completed NCT02058433
Safety Study of Individual Paclitaxel Dose Adjustment Based on Pharmacokinetics in Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 3 unknown_status NCT02967133
A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer treatment 2 terminated NCT02568033
Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer treatment 0 unknown_status NCT02473133
Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC No drug interventions treatment 2 unknown_status NCT06452433
Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer. treatment 2 not_yet_recruiting NCT03116633
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy No drug interventions Not Available Not Available completed NCT01630733
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer treatment 3 unknown_status NCT04258033
A Study of PLB1001 in Non-small Cell Lung Cancer With c-Met Dysregulation(KUNPENG) treatment 2 recruiting NCT02495233
A Study of ASP2215 in Combination With Erlotinib in Subjects With Epidermal Growth Factor Receptor (EGFR) Activating Mutation-Positive (EGFRm+) Advanced Non-Small-Cell Lung Cancer (NSCLC) Who Have Acquired Resistance to an EGFR Tyrosine Kinase Inhibitor (TKI) treatment 1 / 2 terminated NCT02974933
Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer treatment 2 unknown_status NCT03064854
PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients treatment 1 terminated NCT05085054
Salvage Surgery Following Downstaging of Advanced Non-small Cell Lung Cancer by Targeted Therapy (SDANT) treatment 2 unknown_status NCT06109454
Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After Radical Surgery No drug interventions Not Available Not Available recruiting NCT03811054
The Efficacy and Drug Resistance Molecular Biology of Apatinib Combined With EGFR-TK1 Treated for Advanced Slow-progressed Non-Small Cell Lung Cancer (NSCLC) treatment 2 unknown_status NCT02423954
Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) treatment 1 / 2 terminated NCT03518554
A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors treatment 1 unknown_status NCT01577654
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer treatment 2 completed NCT02921854
Detection of Circulating Biomarkers of Immunogenic Cell Death No drug interventions other Not Available completed NCT00442754
Dendritic Cells in Lung Cancer No drug interventions treatment 2 completed NCT00063154
Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy treatment 2 completed NCT06336954
Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure treatment 2 not_yet_recruiting NCT01885754
Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT02778854
Liquid Biopsy for Detection of Driver Mutation in NSCLC No drug interventions Not Available Not Available unknown_status NCT04641754
A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung Cancer treatment 2 unknown_status NCT00896454
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium treatment 2 completed NCT06083454
Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC) treatment 1 recruiting NCT00831454
Identification of EGFR-TKIs Sensitivity or Resistance Markers in NSCLC May Help in Optimal Patient Selection No drug interventions Not Available Not Available completed NCT02839954
CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor treatment 1 / 2 unknown_status NCT02930954
Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance treatment 2 unknown_status NCT02779751
A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer treatment 1 active_not_recruiting NCT02448251
Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung Cancer treatment 1 terminated NCT00460551
Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer treatment 2 terminated NCT05925751
Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT00402051
Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00430651
Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) treatment 3 completed NCT04317651
Crizotinib in ALK Rearranged Non-small-cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT03527251
Anti-CTLA-4 Antibody Followed by Anti-PD-1 Antibody in Recurrent or Metastatic NSCLC treatment 1 unknown_status NCT04638751
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients No drug interventions Not Available Not Available recruiting NCT04324151
Pembrolizumab Combined With Double Platinum Based Chemotherapy for Potentially Resectable NSCLC No drug interventions Not Available Not Available recruiting NCT02195453
Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer No drug interventions treatment 4 unknown_status NCT03871153
Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer treatment 2 terminated NCT01210053
Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer treatment 2 unknown_status NCT02747953
Gilotrif (Afatinib) in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib treatment 2 completed NCT02342353
Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI) treatment 1 terminated NCT04332653
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT03724253
[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) No drug interventions diagnostic 2 terminated NCT04703153
LIQUIK: LIQUId Biopsy for Detection of Actionable Genomic BiomarKers in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available active_not_recruiting NCT04978753
the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer treatment 2 unknown_status NCT03652077
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies treatment 1 completed NCT06250777
Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases treatment 2 not_yet_recruiting NCT05334277
Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA treatment 2 recruiting NCT01666977
Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT03228277
Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA treatment 2 completed NCT03245177
Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 1 withdrawn NCT02319577
GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial treatment 2 unknown_status NCT01221077
Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene treatment 2 completed NCT00933777
SORAVE - Sorafenib and Everolimus in Solid Tumors treatment 1 completed NCT04374877
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors treatment 1 recruiting NCT06300177
D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure treatment 3 recruiting NCT05171777
A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT04342377
The Canada Lymph Node Score Project: A Crossover Trial No drug interventions diagnostic 3 completed NCT03978377
Cardiopulmonary Toxicity of Thoracic Radiotherapy No drug interventions Not Available Not Available recruiting NCT00967577
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors treatment 1 completed NCT01808677
Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation Therapy No drug interventions Not Available Not Available completed NCT03237377
Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT03573947
Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC treatment 2 completed NCT05861947
A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies No drug interventions treatment 1 recruiting NCT02010047
Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients No drug interventions diagnostic Not Available completed NCT02000947
A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer treatment 1 completed NCT01933347
Third-line Treatment of Gefitinib in NSCLC Patients treatment 2 completed NCT06545747
Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI No drug interventions treatment 3 recruiting NCT01545947
Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer treatment 1 completed NCT01023347
A Trial of Paclitaxel (Genexol®) and Cisplatin Versus Paclitaxel Loaded Polymeric Micelle (Genexol-PM®) and Cisplatin in Advanced Non Small Cell Lung Cancer treatment 2 completed NCT01843647
Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients treatment 2 unknown_status NCT00756847
Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors treatment 1 completed NCT03594747
A Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer treatment 3 completed NCT01640847
MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases treatment 2 withdrawn NCT05001347
A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors treatment 2 completed NCT02977845
Effect of Qigong on the Symptom Clusters of Dyspnea, Fatigue, and Anxiety. No drug interventions supportive_care Not Available completed NCT02983045
A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors treatment 1 / 2 completed NCT01588145
Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients treatment 1 / 2 completed NCT05559645
Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15) treatment Not Available recruiting NCT05785845
Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT00588445
Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene treatment 2 completed NCT00970645
Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung Cancer No drug interventions diagnostic Not Available terminated NCT02014545
Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer treatment 2 withdrawn NCT01540045
Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT04193098
Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLC treatment 1 unknown_status NCT04148898
Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis treatment 2 unknown_status NCT01037998
UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer treatment 2 completed NCT02369198
MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC No drug interventions treatment 1 completed NCT00475098
Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT) treatment 3 completed NCT00178698
Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors treatment 2 unknown_status NCT05574998
First-Line Treatment of Advanced Non-Small-Cell Lung Cancer With Negative Driver Gene: a Multicenter, Single-Arm Trial treatment 2 recruiting NCT05329298
A Phase 1/2 Study of BPI-361175 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 / 2 unknown_status NCT05715398
BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung Cancer treatment 1 / 2 not_yet_recruiting NCT04822298
Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer treatment 1 terminated NCT00049998
Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer treatment 3 completed NCT00351598
Lung Tumour Volume Database No drug interventions Not Available Not Available completed NCT05669105
Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research No drug interventions Not Available Not Available recruiting NCT05452005
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer No drug interventions diagnostic 1 recruiting NCT05288205
Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation treatment 1 / 2 recruiting NCT05103605
Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations Not Available Not Available active_not_recruiting NCT04392505
Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study treatment 2 active_not_recruiting NCT04297605
Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2 treatment 1 recruiting NCT04865705
Neoadjuvant Chemotherapy and Tilelizumab in Stage III（cTNM-IIIA.IIIB）Non-small-cell Lung Cancer treatment 2 unknown_status NCT01871805
A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) treatment 1 / 2 completed NCT04237805
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients No drug interventions treatment 1 / 2 recruiting NCT03663205
A Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous NSCLC treatment 3 completed NCT06180005
Incidence and Characterization of Drivers Oncogenes in the Population With Lung Cancer Afferents to the Cancer Institute in Aviano (IN.ON.D.) No drug interventions Not Available Not Available recruiting NCT05955105
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies treatment 1 / 2 recruiting NCT05819905
Radiomics for prEdiction of lunG cAncer biologY No drug interventions Not Available Not Available active_not_recruiting NCT00913705
Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer treatment 3 completed NCT06479005
ETERNALS: Remote Monitoring in Lung Cancer Patients No drug interventions diagnostic Not Available not_yet_recruiting NCT05251805
The Safety and Feasibility of Costal Bone Marrow Aspiration During Thoracic Surgery No drug interventions basic_science Not Available recruiting NCT00783705
Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia prevention 2 completed NCT03769805
Clinical Study of Anlotinib in Maintenance Treatment of Advanced NSCLC treatment Not Available unknown_status NCT03275597
Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition treatment 1 terminated NCT00240097
Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC) treatment 2 completed NCT00960297
Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC treatment 2 terminated NCT03396497
Study of LYC-55716 With Pembrolizumab in Adult Subjects With Non-Small Cell Lung Cancer treatment 1 unknown_status NCT01598597
An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite) No drug interventions Not Available Not Available completed NCT05144997
Lorlatinib Continuation Study treatment 4 recruiting NCT01459497
Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer No drug interventions treatment 3 completed NCT05347797
Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit No drug interventions diagnostic Not Available unknown_status NCT05012397
Milademetan in Advanced/Metastatic Solid Tumors treatment 2 terminated NCT03958097
Natural Killer(NK) Cell Combined With Programmed Death-1(PD-1) Antibody as Second Line Therapy for Advanced Driver Mutation Negative Non-small Cell Lung Cancer No drug interventions treatment 2 completed NCT06451497
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors No drug interventions other 1 recruiting NCT06255197
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers No drug interventions Not Available Not Available recruiting NCT04041297
Evaluation of NSCLC Patients' Oxygen Uptake On-kinetics at Cycle-ergometer During Prehabilitation No drug interventions Not Available Not Available completed NCT01177397
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma treatment 1 / 2 completed NCT00687297
Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer treatment 2 completed NCT02192697
An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations treatment 1 / 2 terminated NCT00662597
ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer treatment 3 terminated NCT02886897
A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors No drug interventions treatment 1 / 2 unknown_status NCT04153097
Real World Observational Study of Pembrolizumab for Chinese Advanced NSCLC No drug interventions Not Available Not Available recruiting NCT04761783
BESPOKE Study of ctDNA Guided Immunotherapy No drug interventions Not Available Not Available completed NCT06276283
DZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29) treatment 2 recruiting NCT00077883
TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) treatment 1 / 2 completed NCT04266483
Cancer Genome Atlas of China:Lung Cancer No drug interventions Not Available Not Available unknown_status NCT05517083
Feasibility of Intratumoral Washing Fluid for Detecting EGFR Mutations in Lung Cancer No drug interventions diagnostic Not Available recruiting NCT06195683
Serplulimab for Patients With Non-small Cell Lung Cancer (NSCLC) With TPS ≥ 50%: a Prospective, Single-center, Single-arm Phase 2 Study. treatment 2 active_not_recruiting NCT02183883
Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity treatment 2 completed NCT03680183
Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV) Not Available Not Available unknown_status NCT05238883
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors treatment 1 recruiting NCT00773383
A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy. treatment 2 terminated NCT06467383
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced No drug interventions Not Available Not Available not_yet_recruiting NCT02738983
RT Plus EGFR-TKI for Wild-type NSCLC treatment 2 unknown_status NCT01516983
Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation treatment 1 / 2 completed NCT01046383
Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients No drug interventions treatment 3 terminated NCT00826683
Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC) No drug interventions diagnostic 3 completed NCT01998061
Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression treatment 2 unknown_status NCT02468661
A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification treatment 1 terminated NCT02635061
Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell Lung Cancer treatment 1 terminated NCT02549261
Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer treatment Not Available unknown_status NCT06473961
A Phase Ⅰb Study on Autologous GC101 TIL Injection for the Treatment of NSCLC treatment 1 not_yet_recruiting NCT00094861
Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT05008861
Gut Microbiota Reconstruction for NSCLC Immunotherapy treatment 1 unknown_status NCT00536861
Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer treatment 1 completed NCT01799161
Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer treatment 1 withdrawn NCT05085028
A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) treatment 3 recruiting NCT00130728
A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung Cancer treatment 3 completed NCT05163028
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations No drug interventions treatment 1 recruiting NCT01880528
Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer supportive_care 2 completed NCT00866528
Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer treatment 1 completed NCT02044328
Icotinib as an Adjuvant Therapy for Patients With Stage IIA-IIIA Adenocarcinoma With EGFR Mutation treatment 2 completed NCT03209128
Cerebral Prophylactic Irradiation With Saving Hippocampus and Amygdala No drug interventions Not Available Not Available terminated NCT05347628
Assessing the Safety and Efficacy of PLB1004 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 active_not_recruiting NCT05878028
L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC treatment 2 recruiting NCT05226728
Pharmacokinetically-guided on the Individualization of Pembrolizumab Administration in the Treatment of Lung Cancer treatment 1 completed NCT03848611
CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC). treatment 2 unknown_status NCT02716311
Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer treatment 2 completed NCT03510611
A Study to Investigate the Food Effect on the Pharmacokinetics of Ensartinib Capsules in Chinese Healthy Volunteers. treatment 1 completed NCT00888511
Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer treatment 2 completed NCT06403111
FMT+Immunotherapy+Chemotherapy as First-line Treatment for Driver-gene Negative Advanced NSCLC treatment 2 not_yet_recruiting NCT02951611
Effects of Acupuncture Stimulation on Systemic Inflammation No drug interventions treatment Not Available unknown_status NCT00982111
First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin treatment 3 completed NCT04203511
INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301) treatment 3 withdrawn NCT04459611
Neoadjuvant of Sintilimab Combined With Chemotherapy for Resectable NSCLC（neoSCORE） treatment 2 unknown_status NCT02338011
Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases) treatment 2 / 3 unknown_status NCT06297811
Myeloprotection With Trilaciclib in Pan-cancer Population prevention 2 not_yet_recruiting NCT03911193
CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET Deregulation treatment 2 unknown_status NCT05641493
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of HLX208+HLX10 in NSCLC With BRAF V600E Mutation treatment 1 / 2 recruiting NCT05998993
Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO) No drug interventions treatment Not Available not_yet_recruiting NCT04636593
A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC treatment 2 unknown_status NCT02616393
Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases treatment 2 completed NCT04074993
Brigatinib in ALK-positive NSCLC Identified Via Blood-based Assays treatment 2 active_not_recruiting NCT04786093
Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC treatment 2 recruiting NCT05748093
Improving Osimertinib Exposure and Cost-effectiveness Using Pharmacokinetic Boosting With Cobicistat treatment 4 recruiting NCT03132493
Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient Not Available Not Available completed NCT06476093
SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer treatment Not Available recruiting NCT04958993
A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer treatment 1 / 2 terminated NCT04970693
A Study of Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With Oligoprogression No drug interventions treatment 2 unknown_status NCT01473693
Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging No drug interventions Not Available Not Available terminated NCT03217071
Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer treatment 2 completed NCT05802771
Lung Cancer Multi-omics Digital Human Avatars for Integrating Precision Medicine Into Clinical Practice No drug interventions Not Available Not Available not_yet_recruiting NCT00271271
Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients treatment 2 completed NCT06244771
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT01926171
Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases treatment 4 unknown_status NCT01797471
Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer No drug interventions treatment Not Available terminated NCT03519971
Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer treatment 3 active_not_recruiting NCT05287971
Standard of Care Lifestyle Support for Stage III NSCLC Patients No drug interventions Not Available Not Available withdrawn NCT00620971
Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC treatment 2 completed NCT01130571
Establishment and Characterization of Patient-Derived Non-Small Cell Lung Cancer Xenografts and Cell Cultures No drug interventions Not Available Not Available unknown_status NCT03272971
Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors No drug interventions device_feasibility Not Available terminated NCT04180371
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression treatment 1 / 2 recruiting NCT00815971
Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib No drug interventions Not Available Not Available unknown_status NCT05845671
Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations treatment 1 / 2 recruiting NCT01038271
Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) No drug interventions supportive_care Not Available completed NCT02403271
A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors treatment 1 / 2 completed NCT03908671
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT03659578
Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer treatment 2 completed NCT00735878
Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer treatment 1 / 2 terminated NCT00283478
Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer treatment Not Available completed NCT01258478
Lung Cancer Rehabilitation Study No drug interventions treatment Not Available unknown_status NCT05219578
RTX-224 Monotherapy in Patients With Solid Tumors No drug interventions treatment 1 / 2 terminated NCT04215978
Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors treatment 1 active_not_recruiting NCT00175578
Detection of Early Lung Cancer by Serum Protein Expression Profiling No drug interventions Not Available Not Available unknown_status NCT04015778
A Two-arm (Phase 2) Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China treatment 2 unknown_status NCT01943578
Value of Physical Capacity Tests in Lung Cancer No drug interventions Not Available Not Available completed NCT03299478
Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung Cancer No drug interventions Not Available Not Available active_not_recruiting NCT05366478
A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors treatment 1 recruiting NCT04322578
Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping Advanced NSCLC treatment 2 recruiting NCT03499678
Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA No drug interventions Not Available Not Available terminated NCT05777278
Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression treatment 1 / 2 recruiting NCT05296278
Efficacy and Biomarker Explanation of IBI-323 + Bevacizumab Plus Platinum Based Chemotherapy on ALK-Rearranged NSCLC treatment 2 recruiting NCT01528488
Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC No drug interventions prevention 2 / 3 completed NCT03881488
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies treatment 1 active_not_recruiting NCT04852588
Chest Lymph Node Sampling in Patients With Advanced Lung Cancer to be Treated With Curative-intent Radiation Treatment No drug interventions treatment Not Available recruiting NCT05351788
SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer. treatment 2 recruiting NCT06018688
Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients. treatment 2 not_yet_recruiting NCT01707888
VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT05668988
A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28) treatment 3 recruiting NCT00409188
Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START) treatment 3 completed NCT00874588
Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer No drug interventions treatment 1 completed NCT05648188
A2R and Ectonucleotidases Expression in Lung Cancer Circulating Tumor Cells No drug interventions Not Available Not Available not_yet_recruiting NCT05230888
Comprehensive Geriatric Assessment in Elderly Non-Small Cell Lung Cancer Patients No drug interventions Not Available Not Available withdrawn NCT04262388
A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation treatment 2 withdrawn NCT03607188
Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer No drug interventions treatment 1 completed NCT01042288
Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC treatment 2 completed NCT00741988
Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer treatment 2 completed NCT03624907
Daily vs. Non-Daily SBRT for NSCLC No drug interventions treatment Not Available terminated NCT06198907
Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC) treatment 2 not_yet_recruiting NCT02613507
Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer treatment 3 completed NCT02535507
Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung Cancer treatment 2 unknown_status NCT04432207
A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer treatment 1 active_not_recruiting NCT05742607
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE) treatment 2 recruiting NCT02733107
The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer treatment 2 unknown_status NCT04254107
A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer treatment 1 terminated NCT05780307
IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors treatment 1 recruiting NCT05801107
Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients treatment 2 active_not_recruiting NCT04878107
SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and Chemotherapy treatment 2 unknown_status NCT04193007
The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC No drug interventions treatment 2 unknown_status NCT04622007
Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART) treatment 2 active_not_recruiting NCT00874107
Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00763607
Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available completed NCT04702607
Functional Lung Imaging With DECT and 4DCT No drug interventions Not Available Not Available recruiting NCT00499109
Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC treatment 3 completed NCT05430009
Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer treatment 1 recruiting NCT02016209
Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer treatment 2 unknown_status NCT02393209
Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 1 / 2 terminated NCT01977209
Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression treatment 3 unknown_status NCT05313009
Tarlox and Sotorasib in Patients With KRAS G12C Mutations treatment 1 / 2 terminated NCT03624309
Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer treatment 2 unknown_status NCT03008109
Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC treatment 3 unknown_status NCT00867009
A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer treatment 2 completed NCT00614809
Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer treatment 2 unknown_status NCT02871856
International Lung Screen Trial (ILST) No drug interventions screening Not Available active_not_recruiting NCT02215356
Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer treatment 2 unknown_status NCT03629756
A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies treatment 1 completed NCT03568656
Study to Evaluate CCS1477 in Advanced Tumours treatment 1 / 2 recruiting NCT00555256
A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT05987956
Pharmacogenomics IND EXEMPT SNP Clinical Study - Alectinib and Single Nucleotide Polymorphisms health_services_research 2 / 3 not_yet_recruiting NCT03129256
An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT04193956
POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors No drug interventions Not Available Not Available recruiting NCT01938456
Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer treatment 1 withdrawn NCT01950156
Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 completed NCT01459185
A Feasibility Study of Oral Adjuvant Chemotherapy With S-1 No drug interventions treatment 2 completed NCT04580485
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors treatment 1 completed NCT01763385
Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases treatment 2 unknown_status NCT00259285
Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer treatment 2 terminated NCT04875585
Trial Exploring Combined Neoadjuvant Therapy With Pembrolizumab/Lenvatinib + Adjuvant Pembrolizumab in Pat. With NSCLC treatment 2 recruiting NCT03553485
Effects of VNS on RT-induced Inflammation and Prognosis of Patients With NSCLC No drug interventions treatment Not Available unknown_status NCT03017885
Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy No drug interventions Not Available Not Available completed NCT03461185
Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT06436885
An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer treatment 0 recruiting NCT05542485
PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN Study No drug interventions Not Available Not Available recruiting NCT05269485
Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT05704985
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors treatment 1 recruiting NCT03307785
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042 treatment 1 active_not_recruiting NCT01065415
Whole-Body Magnetic Resonance Imaging/Positron Emission Tomography (MRI/PET) in the Staging of Non-Small-Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available completed NCT00199615
Follow-up of Patients With Curative-Intent Surgical Resection for NSCLC No drug interventions diagnostic Not Available completed NCT00752115
Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer treatment 2 / 3 completed NCT00463515
Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC treatment 2 completed NCT01734915
Detecting EGFR T790M Mutations From Circulating Tumor Cells No drug interventions Not Available Not Available completed NCT03512015
A Mobile Supportive Care App for Patients With Metastatic Lung Cancer No drug interventions supportive_care Not Available unknown_status NCT04754815
Study of Pembrolizumab With Single Agent Chemotherapy in Elderly Patients With Advanced NSCLC treatment 2 withdrawn NCT00600015
Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC) treatment 2 completed NCT03242915
Pembrolizumab in Combination With Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients With Targetable Genetic Alterations, Previously Treated With Appropriate Targeted Agents, With Progressive Disease treatment 2 active_not_recruiting NCT05477615
Lazertinib/Pemetrexed/Carboplatin After Osimertinib Failure in NSCLC With Brain Metastases treatment 2 not_yet_recruiting NCT04726215
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer No drug interventions diagnostic 2 recruiting NCT04510415
Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI treatment 1 terminated NCT00718315
A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash. treatment 3 completed NCT02591615
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC treatment 2 completed NCT03090737
Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 completed NCT05919537
Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation treatment 1 recruiting NCT05549037
Effect of Time-of-Day (ToD) for Immunochemotherapy on PFS in NSCLC treatment 3 recruiting NCT03700437
Fasting-mimicking Diet With Chemo-immunotherapy in Non-small Cell Lung Cancer (NSCLC) No drug interventions supportive_care Not Available completed NCT04644237
Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC) treatment 2 active_not_recruiting NCT04258137
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study No drug interventions other Not Available recruiting NCT06007937
A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer treatment 1 / 2 recruiting NCT06245837
Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations No drug interventions Not Available Not Available recruiting NCT04133337
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC treatment 1 / 2 unknown_status NCT01944137
Improving Care After Chemotherapy No drug interventions supportive_care Not Available completed NCT04646837
Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models treatment 1 / 2 recruiting NCT00809237
Hydroxychloroquine and Gefitinib to Treat Lung Cancer treatment 1 / 2 unknown_status NCT03736837
Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC treatment 2 completed NCT04619537
A Trial of Anlotinib Combined With Docetaxel in Patients With Wild-type Advanced Non-squamous Non Small Cell Lung Cancer treatment 2 unknown_status NCT00901537
Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer treatment 1 terminated NCT03432637
Clinical Trial of Thoracoscopic Lobecotmy Under Spontaneous Ventilating Anesthesia No drug interventions treatment 3 unknown_status NCT02538432
Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors treatment 2 withdrawn NCT00379132
131-I-TM-601 Study in Adults With Solid Tumors treatment 1 completed NCT05098132
Phase 1a/1b Study of STK-012 Monotherapy and in Combination With Pembrolizumab in Patients With Solid Tumors treatment 1 recruiting NCT01996332
A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT05983432
Study to Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors No drug interventions treatment 1 recruiting NCT03774732
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer treatment 3 recruiting NCT01788332
Parp Inhibitor in Advanced Non-Small Cell Lung Cancer (PIN) treatment 2 unknown_status NCT01772732
Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC No drug interventions treatment 1 unknown_status NCT05254132
Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging No drug interventions Not Available Not Available not_yet_recruiting NCT03517332
Circulating Tumor DNA Exposure in Peripheral Blood No drug interventions Not Available Not Available unknown_status NCT04930432
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04244552
A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies treatment 1 terminated NCT02906852
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing No drug interventions Not Available Not Available completed NCT02193152
Pazopanib in Molecularly Selected Patients With Advanced NSCLC treatment 2 terminated NCT02113852
Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients No drug interventions Not Available Not Available completed NCT03836352
Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors treatment 2 active_not_recruiting NCT02223052
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies treatment 1 completed NCT01721252
Tarceva. ICORG 08-41 No drug interventions Not Available Not Available completed NCT05752552
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours No drug interventions treatment 1 recruiting NCT01631552
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer treatment 1 / 2 completed NCT05613452
Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer No drug interventions treatment 2 recruiting NCT03603652
NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung No drug interventions treatment Not Available terminated NCT06052852
Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies treatment 1 / 2 recruiting NCT00707252
Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer treatment 1 terminated NCT00731952
Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung Cancer other 1 completed NCT00787852
A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC) treatment 1 terminated NCT03907852
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer treatment 1 / 2 active_not_recruiting NCT06185400
RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations treatment 2 not_yet_recruiting NCT02262000
Phase II Image Guided Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer No drug interventions treatment Not Available terminated NCT00319800
Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC treatment 2 unknown_status NCT06182800
Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy treatment 2 not_yet_recruiting NCT03411200
Patient Activation Through Counseling, Exercise and Mobilization No drug interventions supportive_care Not Available completed NCT01752400
AUY922 for Advanced ALK-positive NSCLC treatment 2 completed NCT05245500
Phase 1/2 Study of MRTX1719 in Solid Tumors With MTAP Deletion treatment 1 / 2 recruiting NCT04382300
Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions treatment 2 unknown_status NCT04950400
A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC treatment Not Available unknown_status NCT00529100
Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer treatment 1 / 2 completed NCT04440800
Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment No drug interventions Not Available Not Available unknown_status NCT02447900
Marker Guided Breathhold Radiotherapy in NSCLC No drug interventions treatment 1 completed NCT03056300
A Prospective, Multi-Center Evaluation of a Powered Vascular Stapler in Video-Assisted Thoracoscopic Lobectomies No drug interventions other Not Available completed NCT06221800
Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects No drug interventions Not Available Not Available recruiting NCT02661100
A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients treatment 1 / 2 withdrawn NCT01929200
Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation treatment 2 unknown_status NCT01063400
Feasibility Study: Comparison of Performance Status With Objective Physical Activity Monitors No drug interventions Not Available Not Available terminated NCT06475300
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors No drug interventions treatment 2 recruiting NCT03874000
Sintilimab Combined With Metformin in First-Line Chemotherapy Refractory Advanced NSCLC Patients treatment 2 unknown_status NCT00567359
Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR treatment 2 completed NCT04289259
Tumor Mutational Burden in Lung Cancer Patients No drug interventions Not Available Not Available terminated NCT01058759
Taxotere-Enoxaparin-(ENOXA)-Study treatment 3 terminated NCT05769959
Study of RO7515629 in Participants With HLA-G Positive Solid Tumors treatment 1 terminated NCT00252759
Iressa Case Control Study in Japan No drug interventions Not Available Not Available completed NCT04960059
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts No drug interventions Not Available Not Available recruiting NCT03141359
Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC treatment 2 active_not_recruiting NCT04401059
Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study treatment 4 recruiting NCT02911259
Suction on Post-Operative Chest Tubes No drug interventions treatment Not Available completed NCT00490659
Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes treatment 2 completed NCT03307759
Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma treatment 1 completed NCT03419559
Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Cancer treatment 2 withdrawn NCT00642759
Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT03982459
National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC No drug interventions supportive_care Not Available completed NCT02659059
Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT03838159
NADIM II: Neo-Adjuvant Immunotherapy treatment 2 active_not_recruiting NCT01557959
Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT05084859
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors treatment 1 terminated NCT00259675
Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC treatment 2 completed NCT02491775
Afatinib Genomic Landscape No drug interventions Not Available Not Available terminated NCT04262375
A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION treatment 2 withdrawn NCT02755675
uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung No drug interventions Not Available 2 unknown_status NCT06331975
Radiomics and Radiogenomics of Non-small Cell Lung Cancer No drug interventions diagnostic Not Available completed NCT01139775
A Study in Non Small Cell Lung Cancer treatment 1 / 2 completed NCT01243775
BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC treatment 2 completed NCT00745875
ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study treatment 2 completed NCT03765775
Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative treatment 2 unknown_status NCT04768075
Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC treatment 3 unknown_status NCT00372775
Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases treatment 2 completed NCT00496275
Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC treatment 1 completed NCT03358875
Comparison of Efficacy and Safety of Anti-PD-1 Antibody BGB-A317 Versus Docetaxel as Treatment in the Second- or Third-line Setting in Participants With NSCLC treatment 3 completed NCT03150875
A Study Comparing the Efficacy and Safety Between IBI308 and Docetaxel in Patients With Advanced or Metastatic NSCLC treatment 3 completed NCT00883675
Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer treatment 4 completed NCT04942275
Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy No drug interventions other 2 / 3 unknown_status NCT01902875
Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) Immunotherapy Not Available Not Available unknown_status NCT02273375
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC treatment 3 active_not_recruiting NCT04623775
A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) treatment 2 active_not_recruiting NCT03460275
Osimertinib as First-line Therapy for Patients With Late-stage Lung Cancer treatment 2 unknown_status NCT04536675
Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery treatment 3 unknown_status NCT05132075
Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer treatment 3 active_not_recruiting NCT04213170
Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer treatment 2 unknown_status NCT03219970
Efficacy and Safety of Osimertinib for HK Chinese With Metastatic T790M Mutated NSCLC-real World Setting. Not Available Not Available completed NCT04640870
The Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients With Advanced EGFR Mutation-positive Non-small Cell Lung Cancer Treated With Afatinib Not Available Not Available completed NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02007070
Study of Pembrolizumab (MK-3475) in Participants With Advanced Non-small Cell Lung Cancer (MK-3475-025/KEYNOTE-025) treatment 1 completed NCT06147570
A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer No drug interventions treatment 2 recruiting NCT01158170
Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001) prevention 3 unknown_status NCT03704870
Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection No drug interventions other 2 completed NCT00755170
Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer treatment 2 completed NCT02961270
Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation treatment 2 unknown_status NCT05431270
Dose Escalation/Expansion Study of PT199 (an Anti-CD73 mAb) Administered Alone and in Combination With a PD-1 Inhibitor (the MORNINGSTAR Study) treatment 1 recruiting NCT02055170
Neoadjuvant Finasteride for Patients With Non-small Cell Lung Cancer treatment 2 terminated NCT00977470
Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations treatment 2 unknown_status NCT04136470
BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics Not Available Not Available unknown_status NCT00701870
Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer supportive_care 2 terminated NCT04069442
cDC1 Prognostic and Predictive Role in Non-Small-Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors No drug interventions Not Available Not Available withdrawn NCT00459342
Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT00803842
Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash supportive_care Not Available withdrawn NCT05784142
Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC) No drug interventions treatment 2 active_not_recruiting NCT04060342
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma treatment 1 terminated NCT06235242
GT201 Injection in Combination With Teraplizumab Injection for Treatment of Patients With Non-small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT00859742
Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA) for Mediastinal Re-staging of Non-small Cell Lung Cancer(NSCLC) No drug interventions diagnostic Not Available withdrawn NCT02604342
Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib treatment 3 completed NCT03375242
Safety and Efficacy of Xalkori ROS1 Not Available Not Available recruiting NCT00234442
Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer treatment 2 terminated NCT00419042
Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC) Not Available Not Available completed NCT01789099
A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer. treatment 1 / 2 unknown_status NCT02835599
Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now No drug interventions Not Available Not Available terminated NCT05520099
Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform No drug interventions Not Available Not Available recruiting NCT05013099
Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies diagnostic 2 active_not_recruiting NCT03770299
An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease treatment 2 withdrawn NCT03631199
Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects treatment 3 active_not_recruiting NCT05603299
Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' Dawn Test No drug interventions diagnostic Not Available withdrawn NCT03713099
NEUWAVE Flexible Probe Study #2 No drug interventions treatment Not Available withdrawn NCT01828099
LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer treatment 3 completed NCT02910999
Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy No drug interventions Not Available Not Available completed NCT04153799
Study of CXCR5 Modified EGFE Chimeric Antigen Receptor Autologous T Cells in EGFR- Positive Patients With Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 unknown_status NCT00491699
Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer treatment 1 terminated NCT04152499
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies treatment 1 / 2 recruiting NCT03389399
Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary Events With Brigatinib Use in NSCLC and Other Diseases No drug interventions Not Available Not Available active_not_recruiting NCT02376699
Safety Study of SEA-CD40 in Cancer Patients treatment 1 terminated NCT02364999
A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC treatment 3 completed NCT02573506
Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer No drug interventions treatment 2 completed NCT00390806
Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer treatment 3 completed NCT06248606
Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases treatment 2 recruiting NCT02764606
CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer Not Available Not Available recruiting NCT00409006
Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers treatment 2 completed NCT04923906
Aumolertinib With or Without Chemotherapy as 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Sensitizing EGFR Mutations treatment 3 recruiting NCT05937906
Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %. treatment 1 / 2 not_yet_recruiting NCT03215706
A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC treatment 3 active_not_recruiting NCT02275806
Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC treatment 2 terminated NCT02013206
A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy treatment 2 completed NCT05880706
A Study of BL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 recruiting NCT04722406
Tumor Growth Rate (TGR) Predicts Clinical Outcomes for Advanced Non-small Cell Lung Cancer Undergoing Immunotherapy. No drug interventions Not Available Not Available unknown_status NCT02651506
Electromagnetic Navigational Bronchoscopy Vs. Transthoracic Needle Biopsy for the Sampling of Peripheral Lung Nodules No drug interventions diagnostic 2 withdrawn NCT05588206
Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT03425006
Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung Cancer treatment 2 terminated NCT05234606
A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors treatment 1 / 2 withdrawn NCT05255406
Efficacy and Safety of Furmonertinib in EGFR-Mutant, PD-L1+ Patients With Locally Advanced or Metastatic NSCLC (FUTURE) treatment 2 recruiting NCT05122806
Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC No drug interventions basic_science Not Available recruiting NCT05507606
Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations treatment 2 unknown_status NCT05949606
A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT01784549
Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease treatment 2 unknown_status NCT02681549
Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT00423449
Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058) treatment 1 completed NCT02442349
Phase II Single Arm Study of AZD9291 to Treat NSCLC Patients in Asia Pacific treatment 2 active_not_recruiting NCT04706949
Pyrotinib Combined With Pemetrexed Plus Carboplatin in the First-line Treatment treatment 2 unknown_status NCT00621049
Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC treatment 2 completed NCT04758949
FL-101 in Surgically Resectable Non-Small Cell Lung Cancer treatment 2 withdrawn NCT06192849
To Assess the Efficacy and Safety of Furmonertinib in Patients With Epidermal Growth Factor Receptor 20ins Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy No drug interventions treatment 2 recruiting NCT02151149
Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly treatment 4 completed NCT00318136
A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) treatment 2 completed NCT02980536
cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China No drug interventions Not Available Not Available unknown_status NCT02273336
Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer No drug interventions Not Available Not Available completed NCT05858736
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05754736
Clinical Study of Ametinib Combined With Bevacizumab in First-line Treatment of Advanced NSCLC With EGFR-mutations. treatment 2 recruiting NCT03679936
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT02357836
Neoadjuvant Itraconazole in Non-small Cell Lung Cancer treatment 0 completed NCT02495636
Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent Non-Small Cell Lung Cancer treatment 2 withdrawn NCT00192036
Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer treatment 2 completed NCT02038413
State of the Art Photon Therapy Versus Particle Therapy for Small Lung Tumors; a Planning Study Based on a Reference Dataset of Patients No drug interventions Not Available Not Available completed NCT02475213
Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer treatment 1 completed NCT04316013
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: The VAPOR-C Trial other 3 recruiting NCT04795713
Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1 No drug interventions treatment 1 recruiting NCT03343613
A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors No drug interventions treatment 1 terminated NCT04258813
Onco-primary Care Networking to Support TEAM-based Care No drug interventions prevention Not Available recruiting NCT03543813
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL No drug interventions treatment 1 / 2 completed NCT05617313
Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT06071013
Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients treatment 1 / 2 not_yet_recruiting NCT06554613
Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC treatment 2 not_yet_recruiting NCT05244213
Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC treatment 2 active_not_recruiting NCT04474613
Liquid Biopsy to Reduce Time to Treatment for Advanced Nonsquamous NSCLC Diagnosed at Outside Sites No drug interventions diagnostic Not Available active_not_recruiting NCT00452413
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer treatment 1 / 2 completed NCT05979818
Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer treatment 1 not_yet_recruiting NCT05751018
Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer treatment 2 recruiting NCT06124118
Tumor Treating Fields for Locally Advanced NSCLC treatment 1 recruiting NCT05800418
Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy Male Volunteers treatment 1 completed NCT02497118
Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC treatment 4 completed NCT04198818
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors No drug interventions treatment 1 / 2 terminated NCT02507518
Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung Cancer No drug interventions other 2 unknown_status NCT02725918
Pemetrexed vs Pemetrexed Plus Cisplatin in EGFR-mutant NSCLC Patients After First Line EGFR-TKIs Failure treatment 2 unknown_status NCT03599518
DS-1205c With Gefitinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer treatment 1 terminated NCT01390818
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT02444819
Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy treatment 2 completed NCT00312819
Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer treatment 2 / 3 completed NCT00832819
E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC) treatment 1 completed NCT03968419
This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC. treatment 2 terminated NCT03514719
PD-L1 Imaging in Non Small Cell Lung Cancer' (PINNACLE) diagnostic 1 completed NCT05900219
Efficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical Study treatment 2 not_yet_recruiting NCT05949619
A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer or Other Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06530719
A Study to Evaluate the Efficacy of Osimertinib in Patients With EGFR-sensitive Mutated Non-small Cell Lung Cancer Progression After Receiving Adjuvant Targeted Therapy Following Radical Surgery treatment 2 not_yet_recruiting NCT05805319
Dietary Intervention for NSCLC Patients Treated With ICI No drug interventions treatment Not Available recruiting NCT01998919
A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer. treatment 2 completed NCT03847519
Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT01139619
A Retrospective Study to Investigate the Current Situation of Biopsy Testing in Swedish Inoperable Non Small Cell Lung Cancer (NSCLC) Patients No drug interventions Not Available Not Available completed NCT00099541
Non-small Cell Lung Cancer Registry treatment 4 completed NCT02651441
D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC) treatment 1 / 2 unknown_status NCT00828841
Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC treatment 2 completed NCT01968941
Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients No drug interventions treatment 3 completed NCT03427541
A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases No drug interventions Not Available Not Available unknown_status NCT02353741
Concurrent EGFR-TKIs and Thoracic Radiation Therapy in Active EGFR Mutation for 1st Line Treatment of Stage IV NSCLC No drug interventions treatment 2 terminated NCT03059641
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China No drug interventions Not Available Not Available completed NCT00540241
Performance Status During Treatment With Pemetrexed in Patients With NSCLC Not Available Not Available completed NCT05919641
LIVELUNG - Impact of CGA in Patients Diagnosed With Localized NSCLC Treated With SBRT No drug interventions Not Available Not Available recruiting NCT00794417
A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma treatment 1 / 2 terminated NCT03198117
Huaier Granule for Prevention of Recurrence and Metastasis of Stage II and III Non-small Cell Lung Cancer (NSCLC) No drug interventions prevention Not Available terminated NCT03900117
Hypofractionated Radiotherapy Followed by Hypo-boost for Local Advanced NSCLC No drug interventions treatment 2 completed NCT04322617
Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer treatment 2 / 3 recruiting NCT04941417
Neoadjuvant Immunotherapy With Chemotherapy for Stage I-IIIB Non-Small Cell Lung Cancer Patients No drug interventions treatment 2 unknown_status NCT00460317
MONET1-MOtesanib NSCLC Efficacy and Tolerability Study treatment 3 terminated NCT01291017
Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC. treatment 2 completed NCT06364917
DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC treatment 2 not_yet_recruiting NCT02804217
Acquired Resistant Mechanism of the First-generation EGFR TKIs No drug interventions Not Available Not Available unknown_status NCT06467617
Adebrelimab Plus Chemo and Recaticimab Perioperative Treatment for Resectable NSCLC treatment 2 not_yet_recruiting NCT00832117
Phase I Combination Ixabepilone + Cisplatin treatment 1 completed NCT03764917
NGS Combined With RNAseq on Tumor Immune Escape in NSCLC No drug interventions Not Available Not Available unknown_status NCT04892017
A Phase 1/2 Study of DCC-3116 in Patients With RAS/MAPK Pathway Mutant Solid Tumors treatment 1 / 2 recruiting NCT02002117
Genotyping of Non-small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT05738317
Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment treatment 2 recruiting NCT05426317
Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression No drug interventions other Not Available unknown_status NCT00997334
Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC treatment 2 completed NCT02584634
Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101) treatment 1 / 2 terminated NCT00762034
A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer treatment 3 completed NCT05425134
Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung Cancer No drug interventions Not Available Not Available recruiting NCT02480634
Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer treatment 4 unknown_status NCT06363734
Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial treatment 2 recruiting NCT01813734
Ponatinib in Advanced NSCLC w/ RET Translocations treatment 2 completed NCT01625234
Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT04311034
A Study of RC48-ADC in Subjects With Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 completed NCT03689634
Move For Surgery - A Novel Preconditioning Program No drug interventions prevention 3 completed NCT03982134
PDR001 + Panobinostat for Melanoma and NSCLC treatment 1 withdrawn NCT00862134
Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC) treatment 2 terminated NCT05089734
Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT01066234
Adjuvant CCRT vs CT in Minimal N2 NSCLC No drug interventions treatment 2 completed NCT00321334
Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC No drug interventions treatment 3 completed NCT00758134
Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients treatment 2 terminated NCT05378334
Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients No drug interventions treatment Not Available recruiting NCT03902834
Move for Surgery (MFS): Evaluating the Use of Wearable Technology for Preconditioning Before Thoracic Surgery No drug interventions other Not Available completed NCT03800134
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer treatment 3 active_not_recruiting NCT02540824
Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer treatment 2 unknown_status NCT01586624
A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1) treatment 1 completed NCT02734524
A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer treatment 2 unknown_status NCT05786924
A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers No drug interventions treatment 1 recruiting NCT06300424
Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC treatment 2 recruiting NCT03233724
Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas treatment 1 / 2 terminated NCT00633724
Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer No drug interventions treatment 1 completed NCT04581824
Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) treatment 2 active_not_recruiting NCT06564324
A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients treatment 3 not_yet_recruiting NCT01171924
A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors treatment 1 completed NCT00173524
PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available unknown_status NCT02452424
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors treatment 1 / 2 terminated NCT04939324
Molecular Profiling of Exosomes in Tumor-draining Vein of Early-staged Lung Cancer No drug interventions diagnostic Not Available active_not_recruiting NCT01398124
Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung Cancer No drug interventions treatment Not Available withdrawn NCT01099124
Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC) No drug interventions treatment Not Available completed NCT04905316
A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer treatment 2 active_not_recruiting NCT06370416
the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib prevention 2 not_yet_recruiting NCT01924416
Lung Cancer Information Study (LCIS-R01) No drug interventions supportive_care Not Available completed NCT05383716
Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy treatment 2 active_not_recruiting NCT04879316
Energy for Lymphocytes No drug interventions Not Available Not Available completed NCT06382116
A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 3 recruiting NCT00246116
Functional Imaging of Treatment Effects: A Companion Protocol to a Study of Extracranial Stereotactic Radioablation in Early Stage Non-Small Cell Lung Cancer No drug interventions other Not Available completed NCT03267316
A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors treatment 1 / 2 completed NCT06168916
AIMN Multicenter Study: 18 F-FDG PET-CT With or Without Contrast Medium in the Staging and Radiation of Lung Cancer? No drug interventions Not Available Not Available completed NCT00113516
A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer treatment 2 completed NCT03710616
A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals No drug interventions Not Available Not Available unknown_status NCT02387216
A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC treatment 2 terminated NCT02015416
A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer treatment 1 completed NCT06484816
TGRX-1942 Chinese Phase I for Advanced Solid Tumor and/or Relapsed/Refractory Hematologic Malignancies No drug interventions treatment 1 not_yet_recruiting NCT04025216
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers treatment 1 terminated NCT03750916
Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer treatment 2 unknown_status NCT00870116
Stereotactic Body Radio Therapy (SBRT) for Early-stage Non Small Cell Lung Cancer (NSCLC) No drug interventions treatment Not Available unknown_status NCT02437916
Safety Study of AMG 228 to Treat Solid Tumors No drug interventions treatment 1 terminated NCT05314296
Osimertinib for Russian EGFR T790M Mutation-positive NSCLC Patients Who Progressed on or After EGFR TKI Therapy No drug interventions Not Available Not Available unknown_status NCT01081496
Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available completed NCT04211896
Anlotinib Combined With Nivolumab for Non-Small Cell Lung Cancer treatment 2 unknown_status NCT01000896
Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel treatment 1 withdrawn NCT05259696
Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) treatment 1 / 2 active_not_recruiting NCT02978196
99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLC No drug interventions diagnostic 0 completed NCT01362296
An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer treatment 2 completed NCT00735696
A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer treatment 2 completed NCT02001896
Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR Mutation treatment 3 unknown_status NCT06579196
Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1 treatment 1 / 2 not_yet_recruiting NCT06557096
CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC treatment 0 not_yet_recruiting NCT01570296
A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR treatment 1 completed NCT05060796
Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLC No drug interventions treatment 0 recruiting NCT06516796
Omitting of Lymphadenectomy is Acceptable for Lung Cancer Smaller Than 6 mm in Solid Size No drug interventions Not Available Not Available completed NCT05860296
Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers treatment 1 / 2 recruiting NCT04068896
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy No drug interventions treatment 1 / 2 completed NCT03774758
Biomarkers for Risk Stratification in Lung Cancer No drug interventions Not Available Not Available recruiting NCT04175158
Clinical Trial in Chinese Healthy Volunteers of GB222 treatment 1 unknown_status NCT02031458
A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 2 completed NCT05415358
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients No drug interventions Not Available Not Available recruiting NCT00674258
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer No drug interventions treatment 1 / 2 unknown_status NCT02067858
An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System No drug interventions other Not Available terminated NCT00818558
The Method ISET (Insulation by Size of Epithelial Tumor Cells) No drug interventions prevention Not Available unknown_status NCT03519958
Epidermal Growth Factor Receptor (EGFR) T790M Mutation Testing Practices in Hong Kong No drug interventions Not Available Not Available withdrawn NCT01597258
Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan) Not Available Not Available completed NCT02672358
Study of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLC treatment 2 withdrawn NCT06082635
TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC) treatment 3 recruiting NCT01383135
Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2 No drug interventions diagnostic 0 completed NCT05393635
ITIL-168 in Advanced Solid Tumors No drug interventions treatment 1 withdrawn NCT04969835
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours No drug interventions treatment 1 recruiting NCT00094835
Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 1 / 2 completed NCT01069835
Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN) No drug interventions Not Available Not Available completed NCT04556435
Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy No drug interventions Not Available Not Available terminated NCT04066335
Study to Evaluate the Safety of Nanoxel M Inj. No drug interventions Not Available Not Available unknown_status NCT04440735
A Study of DSP107 Alone and in Combination With Atezolizumab for Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT03953235
A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens treatment 1 / 2 completed NCT01580735
ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer treatment 2 completed NCT05352035
Multiomics Tumor Evolution Model of NSCLC No drug interventions Not Available Not Available not_yet_recruiting NCT04222335
Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients No drug interventions treatment Not Available recruiting NCT06143735
A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors No drug interventions treatment 2 not_yet_recruiting NCT04154163
Appropriate Dosing to Optimise Personalised Cancer Treatments No drug interventions Not Available Not Available completed NCT02679963
Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer treatment 2 unknown_status NCT03296163
A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT00364663
The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT00885963
A Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer treatment 2 terminated NCT06287463
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway No drug interventions treatment 1 / 2 recruiting NCT01207063
Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC) No drug interventions treatment 2 completed NCT01664663
Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy No drug interventions treatment 2 terminated NCT05337163
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China No drug interventions Not Available Not Available completed NCT00365963
Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers No drug interventions other 3 completed NCT06555263
Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 recruiting NCT04069663
Efficacy of Re-challenge With Immune-Checkpoints Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients: a Retrospective Observational Study No drug interventions Not Available Not Available completed NCT00415363
Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy treatment 2 completed NCT03068663
Microbiota and the Lung Cancer No drug interventions other Not Available recruiting NCT03535363
Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC treatment 1 completed NCT03986463
CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clinical Utility No drug interventions Not Available Not Available completed NCT06110663
A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy treatment 3 not_yet_recruiting NCT02562963
Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor No drug interventions treatment 1 / 2 recruiting NCT04789486
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer treatment 1 / 2 recruiting NCT01951586
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer treatment 2 completed NCT01020786
A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients treatment 4 completed NCT03191786
A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy treatment 3 completed NCT03196986
mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung Cancer treatment 3 completed NCT05319886
Observational Study of the Efficacy and Safety of Anlotinib Combined With Penpulimab in Elderly Lung Cancer Patients Not Available Not Available recruiting NCT01263886
Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer treatment 2 completed NCT01270386
A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer treatment 2 completed NCT00179686
A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer treatment 2 completed NCT02617186
Robotic Lobectomy vs. Thoracoscopic Lobectomy for Early Stage Lung Cancer: RCT No drug interventions treatment Not Available recruiting NCT03390686
A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients treatment 3 active_not_recruiting NCT00418886
Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients treatment 3 completed NCT02284139
Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects No drug interventions treatment 2 / 3 completed NCT05933239
Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients No drug interventions diagnostic 2 recruiting NCT03101839
Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid Tumours No drug interventions treatment 1 completed NCT04793139
Efficacy and Safety of Camrelizumab in Real-World Prospective Study Not Available Not Available not_yet_recruiting NCT00085839
Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2 treatment 2 completed NCT06568939
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) treatment 2 not_yet_recruiting NCT01687439
Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC) treatment 2 completed NCT03257722
Pembrolizumab + Idelalisib for Lung Cancer Study treatment 1 / 2 terminated NCT06358222
Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan No drug interventions Not Available Not Available recruiting NCT00356122
Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00516022
Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination. No drug interventions treatment 2 completed NCT05469022
Neoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy treatment 2 recruiting NCT01407822
Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer treatment 2 / 3 unknown_status NCT00828022
Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer treatment 1 / 2 unknown_status NCT00686322
Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC) treatment 4 completed NCT04309422
Texture Features and PDL1 in CT-PET 18 FDG No drug interventions Not Available Not Available completed NCT00614822
Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer treatment 2 completed NCT00572325
Concurrent Chemo-radiation Form NSCLC to a Individualized MLD No drug interventions Not Available Not Available completed NCT00446225
Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR treatment 3 completed NCT03706625
Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment No drug interventions Not Available Not Available completed NCT02974725
A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma treatment 1 terminated NCT00607425
Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening No drug interventions Not Available Not Available terminated NCT04324125
Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC No drug interventions Not Available Not Available recruiting NCT04159025
EBUS-Miniforceps Biopsy Specimen Acquisition for PD-L1 Testing in Nonsmall Cell Lung Cancer No drug interventions diagnostic Not Available completed NCT05054725
Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies treatment 2 active_not_recruiting NCT05825625
NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing treatment 2 recruiting NCT04302025
A Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer treatment 2 recruiting NCT02760225
Pembrolizumab-PET Imaging No drug interventions diagnostic Not Available completed NCT05360225
Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit No drug interventions Not Available Not Available unknown_status NCT02132325
Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer No drug interventions supportive_care Not Available completed NCT00216125
Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer treatment 3 completed NCT05176925
Tislelizumab Combined With Sitravatinib as Consolidation Treatment Following Concurrent Chemoradiation in Patients With Locally Advanced, Unresectable NSCLC treatment 2 terminated NCT00840125
Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment treatment 2 completed NCT00890825
AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients treatment 2 completed NCT01744925
Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFR treatment 2 unknown_status NCT00373425
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors treatment 3 completed NCT02696525
Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients No drug interventions Not Available Not Available unknown_status NCT05538130
A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors treatment 1 recruiting NCT04165330
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors treatment 1 / 2 active_not_recruiting NCT00862030
CT-Based Versus Conventional Simulation for Palliative Radiotherapy of Non-Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT04895930
Furmonertinib Combined With Anlotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC treatment 2 recruiting NCT03088930
Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer treatment 2 completed NCT06341530
Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer treatment 2 recruiting NCT01167530
Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer treatment 1 unknown_status NCT02542930
Abscopal Effect for Metastatic Non-small Cell Lung Cancer. treatment 2 withdrawn NCT03502330
APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma treatment 1 completed NCT03486730
BT1718 in Patients With Advanced Solid Tumours. No drug interventions treatment 1 / 2 completed NCT04303130
Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC treatment 2 unknown_status NCT02337530
Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC treatment 2 completed NCT04297748
Bioimaging Study of 89Zr-M7824 in NSCLC treatment 1 / 2 terminated NCT06033248
Using Urine Samples to Identify Lung Cancer No drug interventions Not Available Not Available recruiting NCT05121948
A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) No drug interventions treatment 1 terminated NCT00417248
Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer treatment 1 / 2 terminated NCT00708448
Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients diagnostic 1 completed NCT04725448
Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma treatment 2 unknown_status NCT03087448
Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC) treatment 1 terminated NCT01069757
A Study of ARQ 197 in Combination With Erlotinib treatment 1 completed NCT05141357
A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer treatment 2 terminated NCT06083857
PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer treatment 1 / 2 recruiting NCT02075957
Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT03564457
20K Distributed Learning Challenge No drug interventions Not Available Not Available completed NCT00150657
Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer treatment 2 unknown_status NCT00449657
Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC treatment 2 terminated NCT03485326
A Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Osimertinib in Clinical Practice Among Chinese NSCLC Patients No drug interventions Not Available Not Available completed NCT01998126
Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer treatment 1 completed NCT02323126
Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer treatment 2 terminated NCT05987826
Study of Furmonertinib as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutant NSCLC treatment 2 not_yet_recruiting NCT05276726
A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1 treatment 1 / 2 recruiting NCT00442026
Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC treatment 3 terminated NCT00191126
Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC treatment 3 completed NCT02752126
A Randomized Phase III Study of Palliative Radiation of Advanced Central Tumors With Intentional Avoidance of the Esophagus No drug interventions supportive_care Not Available completed NCT03044626
Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC treatment 2 completed NCT03451526
A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT01859026
A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation treatment 1 completed NCT02706626
Trial of Brigatinib After Treatment With Next-Generation ALK Inhibitors treatment 2 terminated NCT04397926
Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung Cancer No drug interventions treatment 1 unknown_status NCT00647426
Phase II Study of Sorafenib + Carboplatin and Docetaxel in First Line Treatment of Stage IIIB/IV NSCLC treatment 2 completed NCT05034926
A Study of Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus No drug interventions Not Available Not Available active_not_recruiting NCT04140526
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC treatment 1 / 2 recruiting NCT02477826
An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT01429766
A Prospective Study of Variation in Breath Holding Times at Various Phases of Respiration During the Course of Radiotherapy Including the Effect of Respiratory Training in Lung Cancer Patients No drug interventions supportive_care 2 unknown_status NCT00380666
The Utility of PET/CT in the Planning of Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer No drug interventions treatment Not Available withdrawn NCT05168566
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 recruiting NCT03444766
Study of Nivolumab for Advanced Cancers in India treatment 4 completed NCT06043466
A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT02407366
Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer treatment 2 unknown_status NCT00847366
Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma treatment Not Available completed NCT04911166
Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy treatment 1 suspended NCT00998166
A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy treatment 2 terminated NCT03836066
Atezolizumab Plus Bevacizumab in First Line NSCLC Patients treatment 2 active_not_recruiting NCT00879866
EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 completed NCT01052766
Breathing Synchronized PET/CT Scans for the Detection of Malignant Lung & Liver Lesions and Assessment of Tumor Glycolysis No drug interventions treatment Not Available terminated NCT00363766
Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer treatment 2 completed NCT00807066
Randomized Gefitinib Trial treatment 3 completed NCT05579366
PRO1184 for Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT02824965
Pembrolizumab + CVA21 in Advanced NSCLC treatment 1 unknown_status NCT02470065
Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer. treatment 2 suspended NCT00231465
Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer treatment 2 completed NCT02590965
A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT02576665
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) treatment 1 terminated NCT03614065
Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC treatment 2 unknown_status NCT02043665
CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200) treatment 1 completed NCT05480865
SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation treatment 1 recruiting NCT01562665
Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf No drug interventions Not Available Not Available completed NCT02498665
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies treatment 1 completed NCT03885765
Complication and Lung Function Impairment Prediction Using Perfusion and CT Air Trapping No drug interventions Not Available Not Available recruiting NCT01934465
Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment No drug interventions Not Available Not Available completed NCT00614965
Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV treatment 2 completed NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry No drug interventions Not Available Not Available recruiting NCT04167774
A Study to Evaluate Camrelizumab in Combination With Nb-Paclitaxel in Patients With Advanced or Metastatic NSCLC treatment 2 unknown_status NCT06394674
High-dose Furmonertinib in the Treatment in Patients With Advanced, Metastatic NSCLC With Progressed After First- or Second-line Treatment With Osimertinib treatment 2 recruiting NCT06219174
Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO) treatment 1 / 2 recruiting NCT05186974
Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) treatment 2 active_not_recruiting NCT00051974
Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT00050674
Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma treatment 2 completed NCT06165874
[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer No drug interventions diagnostic Not Available recruiting NCT04059874
Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate treatment 1 unknown_status NCT05485974
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation No drug interventions treatment 1 recruiting NCT06277674
Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI treatment 2 recruiting NCT04415320
X-396 (Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases treatment 2 unknown_status NCT02005120
Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC treatment 2 unknown_status NCT01652820
Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer treatment 2 completed NCT02646020
Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment treatment 2 completed NCT04732520
Feasibility Study of the Aliya System in the Treatment of Early Stage Non-small Cell Lung Cancer No drug interventions treatment Not Available completed NCT01426620
Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer No drug interventions treatment 2 terminated NCT02308020
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain treatment 2 completed NCT05429320
A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 2 recruiting NCT03574220
Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer treatment 0 withdrawn NCT04116320
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors treatment 1 active_not_recruiting NCT00343720
Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy treatment 2 completed NCT06146920
Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation No drug interventions other Not Available recruiting NCT06569420
Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC No drug interventions treatment 3 active_not_recruiting NCT00667082
NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma other 1 completed NCT04546282
Resistance to Oral Therapy in Lung Cancer No drug interventions Not Available Not Available completed NCT05254782
Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection No drug interventions Not Available Not Available recruiting NCT03621982
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors treatment 1 terminated NCT01803282
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors treatment 1 completed NCT05860582
A Study of [14C]GB491 in Male Healthy Subjects No drug interventions treatment 1 completed NCT03001882
An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00906282
Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer treatment 2 completed NCT01799382
Role of Rapid On-site Evaluation for Mutational Analysis of EBUS-TBNA Specimens No drug interventions diagnostic Not Available completed NCT04036682
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer treatment 1 / 2 recruiting NCT05653882
A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors treatment 1 recruiting NCT04880382
Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients No drug interventions treatment 2 active_not_recruiting NCT00362882
Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT04526782
ENCOrafenib With Binimetinib in bRAF NSCLC treatment 2 recruiting NCT05956782
Breathe Easier II: A Dyad-based Multiple Behavior Intervention No drug interventions supportive_care Not Available completed NCT01482182
Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy No drug interventions Not Available Not Available completed NCT01054482
Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Non-small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT02095782
Chemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor Mutation treatment 2 terminated NCT02152631
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer treatment 3 active_not_recruiting NCT00203931
Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer treatment 2 terminated NCT03724331
Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience No drug interventions other Not Available completed NCT02896231
First-in-human Phase I Study of a Selective c-Met Inhibitor PLB1001 treatment 1 completed NCT00103831
Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer No drug interventions treatment 1 / 2 completed NCT00864331
Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy No drug interventions treatment 3 completed NCT02012231
Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers. treatment 1 terminated NCT04725331
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors treatment 1 / 2 recruiting NCT04165031
A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation treatment 1 / 2 terminated NCT05240131
A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC). treatment 1 / 2 active_not_recruiting NCT04681131
CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC treatment 2 recruiting NCT06542731
An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Docetaxel and Ramucirumab as Second-line Therapy in Patients With Advanced or Recurrent Non-small Cell Lung Cancer treatment 1 active_not_recruiting NCT01812031
Benefits Study of Respiratory-gated PET Acquisition in Lung Disease No drug interventions diagnostic Not Available completed NCT04591431
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy treatment 2 active_not_recruiting NCT03927573
Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker No drug interventions treatment 1 terminated NCT05982873
Expanded Access to ABBV-400 No drug interventions Not Available Not Available available NCT05601973
AMAZE-lung: Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI treatment 2 recruiting NCT04849273
A Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLC treatment 1 terminated NCT00550173
A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer treatment 2 completed NCT00050973
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer treatment 3 completed NCT00378573
Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 2 terminated NCT04909073
Observational Study of Afatinib 30 mg Daily Not Available Not Available recruiting NCT05384873
Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT05275673
A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer treatment 2 terminated NCT04612673
A Phase II Study of Anti-PD-1 Antibody, Sintilimab, as Second-line Therapy for Biomarker-selected Advanced or Metastatic NSCLC treatment 2 unknown_status NCT00372073
Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer treatment 2 terminated NCT06573073
Evaluation of Clinical Performance and IVD Test of LifeOS Digital PCR Liquid Biopsy Kits for EGFR T790M Mutation No drug interventions Not Available Not Available recruiting NCT04903873
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT01168973
A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy treatment 3 completed NCT02577627
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC No drug interventions Not Available Not Available unknown_status NCT03910127
Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（NSCLC） treatment 1 unknown_status NCT01190527
Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer No drug interventions treatment Not Available completed NCT05812027
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors No drug interventions Not Available Not Available recruiting NCT02538627
Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib treatment 1 terminated NCT05068427
Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC. treatment 2 completed NCT03533127
A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer treatment 3 unknown_status NCT01212627
Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer treatment 1 terminated NCT02840227
The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resections No drug interventions treatment Not Available withdrawn NCT02562027
SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer No drug interventions health_services_research Not Available completed NCT06514027
Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations treatment 2 not_yet_recruiting NCT01533727
CIK Cell Transfusion Plus Chemotherapy as Adjuvant Therapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 2 withdrawn NCT06524427
Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR) No drug interventions treatment Not Available recruiting NCT03656627
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease treatment 1 terminated NCT04682327
Gut Microbiota and Cancer Immunotherapy Response No drug interventions Not Available Not Available unknown_status NCT02949076
Skeletal Muscle Atrophy and Dysfunction in Human Cancer No drug interventions basic_science Not Available completed NCT04966676
Study of Nivolumab-Ipilimumab and cfDNA in Lung Cancer treatment 2 active_not_recruiting NCT01928576
Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC. treatment 2 completed NCT05546476
Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 treatment 2 active_not_recruiting NCT05298176
Combining Afatinib and Concurrent Chemotherapy, Followed by Osimertinib and Concurrent Chemotherapy, in Untreated EGFR Positive NSCLC Tumors treatment 2 recruiting NCT04197076
Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB No drug interventions Not Available Not Available recruiting NCT02609776
Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer treatment 1 active_not_recruiting NCT00520676
Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer treatment 3 completed NCT03818776
Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable NSCLC treatment 0 terminated NCT00190476
Elderly NSCLC/D vs DP (JCOG0207) treatment 3 terminated NCT06080776
SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR Mutations No drug interventions treatment 3 recruiting NCT04022876
A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection) treatment 1 terminated NCT02804776
PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery treatment 2 completed NCT01404260
Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer treatment 3 completed NCT01685060
LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib treatment 2 completed NCT06522360
Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2) treatment 2 not_yet_recruiting NCT03658460
Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New Biomarkers No drug interventions Not Available Not Available completed NCT00078260
A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer treatment 3 completed NCT03170960
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 active_not_recruiting NCT00050960
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer treatment 3 completed NCT06341660
To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer (NSCLC) treatment 2 recruiting NCT05627960
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies No drug interventions treatment 1 recruiting NCT06167460
Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC. No drug interventions Not Available Not Available recruiting NCT06034860
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types treatment 1 recruiting NCT01391260
Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC) No drug interventions treatment 2 unknown_status NCT05442060
To Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer prevention 2 recruiting NCT06275360
Repositioning Immunotherapy in VetArans With Lung Cancer treatment 2 recruiting NCT05418660
Observational Retro-prospective Study on PD1/PDL1 Inhibitors Treatment Duration in Patients With NSCLC Not Available Not Available recruiting NCT05076760
MEM-288 Oncolytic Virus Alone and in Combination With Nivolumab in Solid Tumors Including Non-Small Cell Lung Cancer treatment 1 recruiting NCT02879760
Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients treatment 1 / 2 completed NCT00855894
A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer treatment 2 completed NCT04100694
Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor Not Available Not Available available NCT05862194
Retrospective, External Comparator Study of Lazertinib as the 2nd-Line Treatment in Patients With EGFR Mutation+ NSCLC Not Available Not Available completed NCT00265694
Random Trial for Elderly Patients With NSCLC treatment 3 unknown_status NCT03646994
Real World Study on First Line Crizotinib in ROS1 Rearranged Advanced Non-squamous Non-small Cell Lung Cancer Not Available Not Available recruiting NCT01823094
CTP Imaging of Lung Cancer No drug interventions Not Available Not Available completed NCT05284994
TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer treatment 1 / 2 unknown_status NCT03264794
the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer) treatment 4 unknown_status NCT00333294
Phase II Iressa + Irradiation Followed by Chemo in NSCLC treatment 2 completed NCT03091491
Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer treatment 2 terminated NCT04161391
Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations No drug interventions treatment 1 / 2 terminated NCT01820091
Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn® prevention 1 withdrawn NCT04977791
Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT01297491
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer treatment 2 completed NCT03177291
Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC treatment 1 active_not_recruiting NCT04322591
Chemotherapy or Chemotherapy Plus PD-1 Antibody in RET Fusion Positive Advanced NSCLC Patitnts: the POSEIDON Trial No drug interventions Not Available Not Available recruiting NCT03560791
A Review of Low-Dose CT Lung Cancer Screenings in a Community-Based Healthcare System With High Incidence No drug interventions Not Available Not Available completed NCT05955391
TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC) No drug interventions treatment 2 recruiting NCT03858491
Pharmacokinetic Boosting of Osimertinib treatment 0 completed NCT02905591
A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC treatment 2 recruiting NCT05005091
Effect of Preoperative Oral Carbohydrate Administration in Thoracic Surgery Patients No drug interventions prevention Not Available completed NCT03195491
A Study of Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Second-Line Nivolumab Monotherapy in Asia treatment 3 completed NCT05445791
Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations treatment 3 recruiting NCT05171062
Dose Escalation Trial of Bexmarilimab (FP-1305) Plus Pembrolizumab in Non-Small Cell Lung Cancer treatment 1 withdrawn NCT03289962
A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors treatment 1 active_not_recruiting NCT04249362
Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for Chemotherapy treatment 2 completed NCT03603262
Safety, Tolerability and Pharmacokinetics of SH-1028 in Patients With Advanced NSCLC No drug interventions treatment 1 unknown_status NCT06305962
177Lu-anti-PD-L1 sdAb in Metastatic Non-small Cell Lung Cancer treatment 0 recruiting NCT01287962
Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer treatment 3 unknown_status NCT03188562
Comparison of Diagnostic and Therapeutic Efficacy of EBUS-TBNA/EUS-FNA and TEMLA in Operable NSCLC. No drug interventions treatment Not Available completed NCT05619562
Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients No drug interventions Not Available Not Available completed NCT05129462
Consistency of PD-L1 Detecting Method Between E1L3N and 22C3 Monoclonal Antibodies in NSCLC Patients No drug interventions Not Available Not Available completed NCT00354562
A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer treatment 1 / 2 terminated NCT00432562
A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer. treatment 1 completed NCT02365662
A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor No drug interventions treatment 1 terminated NCT02417662
Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer No drug interventions treatment Not Available unknown_status NCT05926180
Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients With EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19) treatment 1 recruiting NCT02391480
A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer treatment 1 completed NCT00883480
Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma health_services_research Not Available completed NCT05637580
Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC No drug interventions Not Available Not Available completed NCT01871480
CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer treatment 2 terminated NCT03293680
Pembrolizumab in Elderly Patients With Advanced Lung Cancer treatment 2 completed NCT03289780
Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects No drug interventions Not Available Not Available active_not_recruiting NCT00956280
Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT00970580
A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer treatment 1 completed NCT00451880
Study of XL281 in Adults With Solid Tumors treatment 1 completed NCT02148380
Combination of Chemotherapy and Gefitinib as First-line Treatment treatment Not Available completed NCT00692380
Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC No drug interventions treatment 1 terminated NCT01893580
Perioperative Rehabilitation in Operation for Lung Cancer No drug interventions treatment Not Available terminated NCT01617980
Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer No drug interventions diagnostic Not Available terminated NCT00173680
Methylation Status of CD44 Promoter Region in Primary Lung Cancer No drug interventions Not Available Not Available unknown_status NCT05424029
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT00277329
Study of XL999 in Patients With Non-small Cell Lung Cancer treatment 2 terminated NCT03514329
Vapor Ablation for Localized Cancer Lesions No drug interventions treatment Not Available not_yet_recruiting NCT06465329
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC) treatment 2 not_yet_recruiting NCT03455829
G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT01837329
Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer treatment 1 completed NCT04510129
A Multicenter Cancer Biospecimen Collection Study No drug interventions Not Available Not Available recruiting NCT04248829
Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301) treatment 3 active_not_recruiting NCT03515629
REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer treatment 3 terminated NCT06118229
A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients No drug interventions Not Available Not Available recruiting NCT03870529
High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer treatment 0 terminated NCT01707329
Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment treatment 2 unknown_status NCT05543629
A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer treatment 1 / 2 active_not_recruiting NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors treatment 1 active_not_recruiting NCT06209229
Role of Neutrophils and Electro-bioluminescence in the Rehabilitation supportive_care 1 completed NCT01574729
Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma No drug interventions treatment 2 unknown_status NCT01456429
Assessment of Invasive Mediastinal Staging in cN1 Lung Cancer. No drug interventions diagnostic Not Available active_not_recruiting NCT03138889
Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 terminated NCT05775289
A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT06195189
Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II treatment 1 / 2 recruiting NCT02973789
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) treatment 3 active_not_recruiting NCT02995889
FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer No drug interventions diagnostic Not Available completed NCT02644889
EGFR Mutation Detection From Advanced NSCLC Patient Tissue and Plasma in EGFR-TKI Treatment No drug interventions Not Available Not Available unknown_status NCT00581789
Erlotinib and Sunitinib in NSCLC treatment 1 completed NCT06084689
Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures treatment 2 not_yet_recruiting NCT05142189
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer treatment 1 recruiting NCT00297089
A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT06171789
PRO1107 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04741789
Treatment Plan CINC280A02001M to Provide Access to Capmatinib, for MET Exon 14 Skipping Non-Small Cell Lung Cancer (NSCLC) Not Available Not Available available NCT05913089
A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer treatment 2 recruiting NCT01520389
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment treatment 1 completed NCT03998189
Metabolic and Microbial Profiling of Lung Cancer No drug interventions diagnostic Not Available terminated NCT02786589
Plasmodium Immunotherapy for Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT00399789
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT04314089
Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902) No drug interventions treatment 1 active_not_recruiting NCT01817192
Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT03306992
Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study No drug interventions treatment 3 completed NCT00903292
Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma screening Not Available unknown_status NCT03371992
Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLC basic_science 0 unknown_status NCT03988192
Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic Response No drug interventions other Not Available terminated NCT05757492
Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors treatment 1 / 2 terminated NCT03647592
Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer Not Available Not Available recruiting NCT01836692
Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study No drug interventions treatment Not Available completed NCT00704392
Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors treatment 1 withdrawn NCT01401192
Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase Expression treatment 2 unknown_status NCT02309892
A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC treatment 1 terminated NCT00370292
Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT02663492
Transcutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer Patients No drug interventions treatment Not Available unknown_status NCT05887492
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors treatment 1 / 2 recruiting NCT01158144
Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902) treatment 2 unknown_status NCT02055144
Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard Chemotherapy No drug interventions Not Available Not Available unknown_status NCT05154344
RW Effectiveness of Capmatinib in Advanced MET-dysregulated NSCLC Included in the French Compassionate Use Program (ATU) Not Available Not Available completed NCT05094544
Pre-Operative Immuno-Modulatory SBRT (POIMS Trial): A Pilot Trial in Early Stage NSCLC No drug interventions treatment Not Available recruiting NCT02031744
A Study of the Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung Cancer treatment 3 completed NCT01026844
Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC) treatment 1 terminated NCT05145244
Copenhagen Master Observational Trial No drug interventions Not Available Not Available unknown_status NCT01201044
Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC) treatment Not Available unknown_status NCT06564844
A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features treatment 3 not_yet_recruiting NCT03002844
EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism treatment 2 unknown_status NCT04282044
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies treatment 1 recruiting NCT03953144
Synapse 3D With Intravascular Indocyanine Green treatment 1 / 2 recruiting NCT03628144
Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer No drug interventions supportive_care 2 withdrawn NCT03754244
A Phase I Study of TQ-B3456 on Tolerance and Pharmacokinetics No drug interventions treatment 1 terminated NCT05277844
Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC No drug interventions treatment 2 recruiting NCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation No drug interventions Not Available Not Available recruiting NCT03202940
A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC treatment 1 / 2 active_not_recruiting NCT01061840
Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer No drug interventions treatment 1 completed NCT05221840
A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer treatment 3 recruiting NCT01100840
A Retrospective Study of Biomarkers in Non-Small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT06434740
A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC No drug interventions treatment 2 not_yet_recruiting NCT03958240
Deciphering Mechanisms Underlying Cancer Immunogenicity No drug interventions other Not Available recruiting NCT03872440
PDX Models From EGFR Mutant Tumors No drug interventions Not Available Not Available withdrawn NCT03088540
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT02075840
A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants treatment 3 active_not_recruiting NCT06582940
Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis No drug interventions treatment 2 recruiting NCT04678440
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients No drug interventions basic_science 0 enrolling_by_invitation NCT01507740
Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients Not Available Not Available terminated NCT05800340
Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC treatment 2 recruiting NCT00680940
A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer treatment 2 completed NCT03833440
Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance treatment 2 active_not_recruiting NCT02802540
Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients treatment 2 / 3 unknown_status NCT05745740
A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation treatment 1 / 2 not_yet_recruiting NCT01069640
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 completed NCT00441740
Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer treatment 3 completed NCT04464967
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers treatment 1 / 2 withdrawn NCT03613467
Is Video-assisted Thoracoscopic Lobectomy a Clinical Alternative for Surgically Resectable Pathologic N2 NSCLC Patients No drug interventions Not Available Not Available completed NCT03427567
A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT01647867
Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers No drug interventions basic_science Not Available completed NCT02708667
An Observational Research Of Crizotinib's Hepatic Toxicity In Non-small Cell Lung Cancer Patients No drug interventions Not Available Not Available unknown_status NCT05872867
Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90) treatment 1 recruiting NCT00198367
Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT02568267
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) treatment 2 active_not_recruiting NCT02777567
KOREA Study (Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy) No drug interventions Not Available Not Available completed NCT05584267
Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy No drug interventions treatment 2 recruiting NCT05837767
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue No drug interventions treatment Not Available recruiting NCT01913067
Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC treatment 2 withdrawn NCT05094167
Lactobacillus Bifidobacterium V9(Kex02)Improving the Efficacy of Carilizumab Combined With Platinum in Non-small Cell Lung Cancer Patients No drug interventions prevention Not Available unknown_status NCT03661567
Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer treatment 2 terminated NCT02998567
Combination Study of Guadecitabine/ASTX727 and Pembrolizumab health_services_research 1 recruiting NCT02189967
Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation No drug interventions treatment Not Available completed NCT03228667
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors treatment 2 active_not_recruiting NCT00243867
Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer treatment 3 completed NCT06424067
Phase 2 Study of Fingolimod in Lung Cancers treatment 2 not_yet_recruiting NCT04332367
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance treatment 2 recruiting NCT04731467
A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT02833467
Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA No drug interventions Not Available Not Available unknown_status NCT00749567
Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer treatment 2 terminated NCT05805267
To Evaluate the Correlation Between the Results of Specific Gene Testing and the Efficacy of Targeted Therapy in Patients With NSCLC No drug interventions Not Available Not Available completed NCT01949701
Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer No drug interventions treatment 1 / 2 completed NCT02927301
A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3) treatment 2 completed NCT00875901
Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03) No drug interventions treatment Not Available completed NCT02731001
Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer No drug interventions treatment Not Available recruiting NCT05355701
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. treatment 1 recruiting NCT05537701
Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study) No drug interventions Not Available Not Available active_not_recruiting NCT02737501
ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants treatment 3 completed NCT03829501
Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer treatment 1 / 2 active_not_recruiting NCT01888601
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx) No drug interventions Not Available Not Available active_not_recruiting NCT02186301
TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy treatment 2 / 3 terminated NCT01004601
Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer treatment Not Available completed NCT01297101
Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy Not Available Not Available temporarily_not_available NCT00712504
Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer treatment 1 completed NCT06567704
Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study No drug interventions Not Available Not Available not_yet_recruiting NCT04500704
Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Non-EGFR Driver Gene Mutant, Locally Advanced or Metastatic NSCLC treatment 3 unknown_status NCT03789604
A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer treatment 3 active_not_recruiting NCT01560104
A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT00609804
Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib treatment 2 completed NCT04547504
PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 % treatment 3 active_not_recruiting NCT06225804
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer No drug interventions treatment 1 recruiting NCT00862004
Video-assisted Thoracoscopic Surgery for Stage IIIA Non-Small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT06224504
Clinical Effectiveness of Combining Mindfulness-Based Stress Reduction With Exercise Interventione No drug interventions supportive_care Not Available completed NCT00102804
Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT02575404
GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients treatment 1 completed NCT05094804
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents treatment 1 / 2 recruiting NCT00707304
Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer treatment 3 completed NCT03076372
A Study Evaluating MM-310 in Patients With Solid Tumors No drug interventions treatment 1 unknown_status NCT00455572
Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer treatment 1 terminated NCT05815472
Advanced Patient Monitoring and A.I. Supported Outcomes Assessment in Lung Cancer Using Internet of Things Technologies (A.I. - APALITT) No drug interventions diagnostic Not Available recruiting NCT01565772
Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer treatment 1 terminated NCT00702572
Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer treatment 1 terminated NCT05716672
Impact of Lazertinib Dose Modification on Effectiveness and Safety Not Available Not Available not_yet_recruiting NCT03311672
T-Cell PET Imaging With [18F]F-AraG in Lung Cancer diagnostic 2 withdrawn NCT05730972
TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer No drug interventions treatment Not Available not_yet_recruiting NCT02127372
Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571 treatment 1 / 2 terminated NCT03322072
Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating No drug interventions treatment Not Available active_not_recruiting NCT01749072
Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients treatment 2 unknown_status NCT04937972
SHR-1701 Combined With Fluzoparib in Lung Squamous Cell Carcinoma treatment 2 recruiting NCT03416972
Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer Radiotherapy No drug interventions Not Available Not Available unknown_status NCT04622072
XZP-5809-TT1 Tablets in Patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer No drug interventions treatment 1 terminated NCT04480372
SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II treatment 2 completed NCT03944772
Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD) treatment 2 active_not_recruiting NCT04206072
D-0316 Versus Icotinib in Patients With Locally Advanced or Metastatic EGFR Sensitising Mutation Positive NSCLC treatment 2 / 3 active_not_recruiting NCT02504372
Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091) treatment 3 active_not_recruiting NCT01947868
Evaluation of Symptoms Improvement in NSCLC Patients With First-Line Therapy of EGFR Tyrosine Kinase Inhibitor No drug interventions Not Available Not Available completed NCT02318368
A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label treatment 2 terminated NCT02409368
An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC other 2 completed NCT04187768
Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT03228368
The Predicted Potential of Quantitative T Cell Repertoire(TCR) in Anti-PD-L1 Treatment in NSCLC Patients Not Available Not Available unknown_status NCT03965468
Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC treatment 2 recruiting NCT02492568
Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC treatment 2 completed NCT02105168
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment No drug interventions screening Not Available unknown_status NCT03198468
Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE) No drug interventions treatment Not Available completed NCT05652868
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer No drug interventions treatment 1 recruiting NCT04699968
A Trial of SHR-1701 With or Without Famitinib in Patients With Advanced or Metastatic NSCLC treatment 2 withdrawn NCT02843568
Improving Pulmonary Function Following Radiation Therapy No drug interventions treatment Not Available active_not_recruiting NCT01189968
A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung Cancer treatment 1 completed NCT03849768
A Study to Evaluate Safety and Efficacy of HS-10296 as First-Line Treatment in Patients treatment 3 active_not_recruiting NCT03003468
Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017 treatment 1 / 2 completed NCT01356368
Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung Cancer treatment 2 terminated NCT01380769
A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT00221169
Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer No drug interventions diagnostic 0 completed NCT02523469
ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT03195569
To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer Not Available Not Available unknown_status NCT03094169
AVID100 in Advanced Epithelial Carcinomas No drug interventions treatment 1 / 2 terminated NCT05811169
Quest for Tumour Evolution of Non-small Cell Lung Cancer No drug interventions Not Available Not Available active_not_recruiting NCT02431169
Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression No drug interventions Not Available Not Available terminated NCT01951469
Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer treatment 3 unknown_status NCT03490669
Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors No drug interventions treatment 1 completed NCT00819169
QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors treatment 1 / 2 terminated NCT04504669
First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours treatment 1 active_not_recruiting NCT03399669
The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation treatment 2 unknown_status NCT05020769
SI-B001 Combined With Osimertinib Mesylate Tablets in the Treatment of Recurrent Metastatic Non-small Cell Lung Cancer. treatment 2 / 3 recruiting NCT00722969
Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer treatment 2 unknown_status NCT01179269
Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer treatment 2 withdrawn NCT03836469
Retrospective Epidemiological Study of Locally Advanced Non Small Cell Lung Cancer Patients in Brazil No drug interventions Not Available Not Available completed NCT03940846
CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology No drug interventions Not Available Not Available unknown_status NCT06288646
Using Infrared Spectroscopy to Analyze Volatile Organic Compounds (VOCs) in the Breath of Patients With Lung Cancer No drug interventions Not Available Not Available terminated NCT05669846
Responder-derived FMT (R-FMT) and Pembrolizumab in Relapsed/Refractory PD-L1 Positive NSCLC treatment 2 not_yet_recruiting NCT00762346
Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis treatment 4 completed NCT00714246
Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer treatment 1 terminated NCT04345146
Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From NSCLC treatment 2 completed NCT06422546
A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC No drug interventions Not Available Not Available recruiting NCT04384146
Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 active_not_recruiting NCT01427946
Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer treatment 1 / 2 completed NCT00034346
ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) treatment 2 completed NCT06163846
Image Mining and ctDNA to Improve Risk Stratification and Outcome Prediction in NSCLC Applying Artificial Intelligence. No drug interventions Not Available Not Available recruiting NCT05990946
Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer No drug interventions supportive_care Not Available recruiting NCT01525446
Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer No drug interventions treatment 0 terminated NCT05555212
To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation No drug interventions treatment 1 recruiting NCT01040312
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors Not Available Not Available completed NCT05369312
Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients No drug interventions treatment 1 not_yet_recruiting NCT06049212
Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008) treatment 1 recruiting NCT06448312
A Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 3 recruiting NCT01222312
Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel treatment 2 completed NCT01124812
131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 terminated NCT04870112
A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer treatment 1 terminated NCT02349412
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers No drug interventions supportive_care 3 completed NCT05257512
Phase I/II Study of SY-3505 in Patients With ALK-positive Advanced Non-small Cell Lung Cancer treatment 1 / 2 recruiting NCT03951012
Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC Immunotherapy No drug interventions Not Available Not Available terminated NCT01327612
Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) treatment 2 completed NCT00556712
A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT04806412
Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study. No drug interventions diagnostic Not Available unknown_status NCT00347412
Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer treatment 3 completed NCT01028612
Thermal Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer > 3.5 cm in Size No drug interventions treatment Not Available terminated NCT02963610
Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer treatment 1 / 2 terminated NCT05082610
A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab treatment 1 recruiting NCT05074810
Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients treatment 1 / 2 recruiting NCT05671510
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors treatment 3 recruiting NCT03825510
Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect No drug interventions treatment 2 completed NCT03999710
Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT03215810
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer treatment 1 completed NCT00864110
Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC) No drug interventions diagnostic 1 completed NCT05015010
Alectinib in Neo-adjuvant Treatment of Stage III NSCLC treatment 2 active_not_recruiting NCT00949910
An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 4 completed NCT03345810
Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION) treatment 2 completed NCT00461110
A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC) treatment 1 terminated NCT02082210
A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer treatment 1 / 2 completed NCT05450081
Association Between the Results of Specific Genetic Tests and the Efficacy of Targeted Therapies in Patients No drug interventions Not Available Not Available completed NCT01106781
A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology No drug interventions Not Available Not Available completed NCT04698681
NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial No drug interventions Not Available Not Available terminated NCT06369181
Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLC No drug interventions Not Available Not Available recruiting NCT03130881
Phase I Study of a Selective ALK Inhibitor PLB1003 in Patients With ALK+ NSCLC. No drug interventions treatment 1 unknown_status NCT03917381
GEN1046 Safety Trial in Patients With Malignant Solid Tumors treatment 1 / 2 active_not_recruiting NCT03758781
IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors treatment 1 completed NCT04849481
The Research Plan of Taiwan Precision Medicine No drug interventions Not Available Not Available recruiting NCT01728181
A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation treatment 1 / 2 withdrawn NCT02322281
TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy treatment 3 terminated NCT01511081
Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT) No drug interventions treatment 2 terminated NCT00246181
Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC No drug interventions treatment 1 / 2 completed NCT05746481
Carboplatin, Pemetrexed, and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases treatment 2 recruiting NCT06311981
Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients No drug interventions treatment 2 recruiting NCT05170581
Clinical Study of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Non-small Cell Lung Cancer treatment 2 recruiting NCT05460481
Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors treatment 2 recruiting NCT05552781
H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC No drug interventions treatment 1 / 2 recruiting NCT04758481
Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT04889495
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer Not Available Not Available not_yet_recruiting NCT01887795
Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study treatment 3 completed NCT06046495
A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer No drug interventions treatment 1 recruiting NCT01066195
Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy treatment 3 unknown_status NCT00741195
Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung Cancer treatment 2 completed NCT01770795
A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer treatment 2 completed NCT01593995
EGF Ointment for Erlotinib Skin Lesion No drug interventions treatment 2 completed NCT00200395
OSI-774 (Erlotinib, Tarceva) in Elderly Patients treatment 2 completed NCT05462795
Liquid Biopsy for Early Non-small Lung Cancer Detection No drug interventions Not Available Not Available active_not_recruiting NCT06051695
A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Subjects With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression No drug interventions treatment 1 / 2 recruiting NCT00517595
Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC treatment 2 completed NCT05254795
Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care No drug interventions other Not Available recruiting NCT00482014
A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer treatment 1 / 2 completed NCT06439914
First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy diagnostic 1 not_yet_recruiting NCT00440414
Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT00576914
Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer treatment 3 unknown_status NCT01185314
To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC) No drug interventions screening Not Available completed NCT05827614
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), in Subjects With Tumors With Oncogene Amplifications treatment 1 recruiting NCT03639714
A Study of a Personalized Neoantigen Cancer Vaccine treatment 1 / 2 completed NCT05024214
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors treatment 1 / 2 recruiting NCT01172314
Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients No drug interventions other Not Available unknown_status NCT02771314
Liquid Biopsy as a Tool to Evaluate Resistance to First and Third (AZD9291) (EGFR) (TKIs) in (EGFR) Mutant NSCLC other 2 unknown_status NCT05229614
Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease treatment 2 recruiting NCT02720614
Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer No drug interventions treatment 2 completed NCT02770014
Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer treatment 2 terminated NCT02381314
Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer treatment 1 completed NCT05136014
Evaluation of the Response to Tyrosine Kinase Inhibitors in Localized Non-small Cell Lung Cancer (NSCLC) Patients With EGFR Mutation in a Patient-derived Organoid Model No drug interventions Not Available Not Available unknown_status NCT00097214
Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT02758314
Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients No drug interventions Not Available Not Available unknown_status NCT05236114
GEMINI-NSCLC: NSCLC Biomarker Study No drug interventions Not Available Not Available recruiting NCT02202655
Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT01982955
Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT) treatment 1 / 2 completed NCT03373955
A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC Patients Not Available Not Available unknown_status NCT01104155
Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT02136355
A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer No drug interventions treatment Not Available completed NCT03689855
Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC treatment 2 completed NCT00958555
A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT00599755
Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3) diagnostic 1 completed NCT02513355
Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research treatment 4 unknown_status NCT05034055
Study of Stereotactic Ablative Radiotherapy(SBRT) Followed by Atezolizumab / Tiragolumab in Treatment-naive Patients With Metastatic Non-small Cell Lung Cancer treatment 2 unknown_status NCT01646450
First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients treatment 4 unknown_status NCT02595450
A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer Not Available Not Available completed NCT01004250
A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer treatment 2 completed NCT05472350
Efficacy and Safety of Perioperative Use of Breztri Aerosphere to Relieve Cough After Lobectomy treatment Not Available unknown_status NCT00359450
Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer) treatment 2 terminated NCT06331650
A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer treatment 2 recruiting NCT03553550
Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation No drug interventions Not Available Not Available terminated NCT02488850
Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC No drug interventions basic_science Not Available recruiting NCT03674450
Lung Heart Rate Variability No drug interventions treatment Not Available withdrawn NCT04828850
Preoperative Lymph Node Staging With EBUS-TBNA in Clinical N0 Non Small-cell Lung Cancer No drug interventions diagnostic Not Available unknown_status NCT02695550
Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer No drug interventions treatment 1 unknown_status NCT02292550
Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer. treatment 1 completed NCT00685750
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma No drug interventions screening Not Available terminated NCT05486650
An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment No drug interventions Not Available Not Available recruiting NCT04029350
Study of Anlotinib Combined With Osimertinib as Second-line Treatment in Stage IIIb-IV NSCLC With Confirmed EGFRm and T790M treatment 2 unknown_status NCT04037150
Circulating DNA in Surgically Treated NSCLC No drug interventions Not Available Not Available unknown_status NCT00655850
Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer treatment 2 completed NCT01156623
Endobronchial Ultrasound Guided Transbronchial Aspiration (EBUS-TBNA) in Non Small Cell Lung Cancer (NSCLC) in a Tuberculosis-endemic Country No drug interventions diagnostic Not Available completed NCT03852823
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours No drug interventions treatment 1 unknown_status NCT04748523
Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia treatment Not Available completed NCT01755923
Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC treatment 2 unknown_status NCT01170923
FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer No drug interventions diagnostic 2 unknown_status NCT03644823
Combinatory ImmunoTherapy-1 (Com-IT-1) Irradiation and PD-1 Blockade in Locally Advanced / Advanced NSCLC treatment 2 terminated NCT05414123
A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide No drug interventions Not Available Not Available terminated NCT01967823
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer treatment 2 completed NCT03083808
Phase II Trial of Continuation Therapy in Advanced NSCLC treatment 2 completed NCT01639508
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity treatment 2 recruiting NCT06228508
Molecular Diagnosis of Lung Cancer Via Bronchoscopy: The Significance of Bronchial Liquid Biopsy (ctDNA and ctRNA) No drug interventions Not Available Not Available not_yet_recruiting NCT03527108
Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC treatment 2 recruiting NCT02340208
A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47 No drug interventions treatment 1 / 2 completed NCT06406608
Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT01860508
A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers treatment Not Available unknown_status NCT05015608
Study on Savolitinib Combined With Osimertinib in Treatment of Advanced NSCLC With MET Amplification treatment 3 recruiting NCT04312308
A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients No drug interventions Not Available Not Available unknown_status NCT05781308
Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy treatment 2 recruiting NCT03840408
Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation for Early-stage Non-small Cell Lung Cancer No drug interventions treatment Not Available unknown_status NCT01714908
Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21 No drug interventions treatment 2 unknown_status NCT01891708
VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT04675008
Central Nervous System(CNS) Efficacy of Dacomitinib treatment 2 unknown_status NCT01260038
Study in NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in Region Antwerp, Belgium. No drug interventions Not Available Not Available completed NCT05007938
Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer treatment 2 active_not_recruiting NCT00743938
A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC treatment 2 completed NCT05117138
Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors No drug interventions treatment 1 / 2 unknown_status NCT04455438
SBRT Dose Escalation for Reirradiation of Inoperable Lung Lesions No drug interventions treatment Not Available recruiting NCT04981938
Pulmonary Function After Arterial Sleeve Lobectomy No drug interventions Not Available Not Available completed NCT04304638
Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLC No drug interventions Not Available Not Available unknown_status NCT02274038
Serial [18F]Thymidine (FLT)PET/CT as a Biomarker of Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer diagnostic Not Available terminated NCT05925738
Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT05374538
VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer treatment 1 terminated NCT06330038
Anesthesia and Non-small Cell Lung Cancer Recurrence prevention 4 not_yet_recruiting NCT04131543
Phase II Study With Cabozantinib in Patients With RET Positive NSCLC treatment 2 unknown_status NCT03798743
Phase II Study on Sintilimab Combined With Docetaxel for Chemotherapy Failure Advanced NSCLC: the SUCCESS Study treatment 2 completed NCT06091943
Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer treatment 1 recruiting NCT01192243
Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients treatment 2 unknown_status NCT03615443
Noninvasive vs. Invasive Lung Evaluation No drug interventions Not Available Not Available completed NCT04440943
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT03917043
APG-2449 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02883543
First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation treatment 3 unknown_status NCT02367443
Hypofractionated Accelerated Radiotherapy With Concomitant Chemotherapy for NSCLC No drug interventions treatment 1 / 2 unknown_status NCT01465243
Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose treatment 4 completed NCT02455843
Microwave Plus Chemotherapy Versus Chemotherapy for Advanced NSCLC No drug interventions treatment 3 unknown_status NCT00690703
Radiofrequency Ablation of Pulmonary Tumors Response Evaluation No drug interventions treatment 2 completed NCT03940703
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2) treatment 2 active_not_recruiting NCT02895503
Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment No drug interventions supportive_care Not Available terminated NCT00694603
Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy treatment 2 terminated NCT00372203
Endobronchial Ultrasound vs Mediastinoscopy in NSCLC No drug interventions diagnostic 2 completed NCT02450903
LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib. treatment 2 completed NCT05513703
A Study to Assess Disease Activity of Intravenously (IV) Infused Telisotuzumab Vedotin in Adult Participants With Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) treatment 2 active_not_recruiting NCT03991403
Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC treatment 3 active_not_recruiting NCT05291403
Efficacy and Safety Study of Medical Thoracoscope Cryotherapy Combined Standard First-line Treatment of Advanced Non-small Cell Lung Cancer and Malignant Pleural Effusion No drug interventions treatment Not Available recruiting NCT04809103
Intratumoral Cisplatin for Resectable NSCLC treatment 1 unknown_status NCT02803203
Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers treatment 1 / 2 completed NCT03740503
Genomic Investigation of Unusual Responders No drug interventions Not Available Not Available recruiting NCT00216203
Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer treatment 1 / 2 completed NCT00265603
Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer No drug interventions treatment 1 terminated NCT06422403
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers No drug interventions treatment 2 not_yet_recruiting NCT00871403
Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer treatment 2 completed NCT01256203
Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light No drug interventions prevention 2 withdrawn NCT01872403
Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung treatment 2 unknown_status NCT00918203
A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT04263090
Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment treatment 1 / 2 completed NCT02835690
Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Pembrolizumab (MK-3475) in Chinese Participants With Non-Small-Cell Lung Cancer (MK-3475-032/KEYNOTE-032) treatment 1 completed NCT01951690
Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer treatment 2 completed NCT04585490
Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC treatment 3 recruiting NCT04650490
SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer No drug interventions treatment 2 withdrawn NCT03735290
A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer treatment 1 terminated NCT05098990
Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC treatment 4 unknown_status NCT01531790
A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients treatment 1 completed NCT01946490
Time Trends in Waiting Times of NSCLC Patients. No drug interventions Not Available Not Available withdrawn NCT05256290
Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations No drug interventions treatment 1 / 2 recruiting NCT02368990
T790M Mutation Positive 2nd Line STandard of cAre Registry No drug interventions Not Available Not Available withdrawn NCT04490564
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma No drug interventions Not Available Not Available active_not_recruiting NCT06281964
Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion. No drug interventions treatment 3 not_yet_recruiting NCT03065764
89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer diagnostic 2 unknown_status NCT03936764
Effect of Two Different Preoperative Training Densities in Patients With Non-small-cell Lung Cancer Before Lung Resection Surgery No drug interventions supportive_care Not Available completed NCT04316364
A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC treatment 3 recruiting NCT01159964
Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery No drug interventions treatment 1 terminated NCT05361564
A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Preoperative Brigatinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harboring ALK Fusions. treatment 2 unknown_status NCT06448364
A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination treatment 1 active_not_recruiting NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT00858364
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy supportive_care 3 terminated NCT00678964
Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 unknown_status NCT05278364
Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor No drug interventions treatment 1 / 2 recruiting NCT03735264
Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034） treatment 2 unknown_status NCT04324164
Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC No drug interventions Not Available Not Available recruiting NCT04867564
Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer Radiotherapy No drug interventions Not Available Not Available unknown_status NCT05296564
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers treatment 1 / 2 recruiting NCT06150664
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT05932264
Apatinib and Fluzoparib With or Without Adebrelimab in Previously-treated TP53-mutant Advanced Non-small Cell Lung Cancer treatment 2 not_yet_recruiting NCT02702921
Powered Vascular Stapler in Video-Assisted Thoracoscopic (VAT) Lobectomies No drug interventions treatment Not Available completed NCT04676321
Key Performance Indicators for the Assessment of NSCLC Patients Pathway No drug interventions Not Available Not Available completed NCT00606021